Howard Gebel PhD
Academic Appointment
- Professor, Department of Pathology and Laboratory Medicine, Emory University School of Medicine
Education
Degrees
- BS from University of Illinois
- PhD from University of Missouri
Research
Focus
- My research studies focus on the immunobiology of transplantation rejection in solid organ allograft recipients. I am particularly interested in how HLA antibodies detected solely by flow cytometric methodologies impact on the development of acute and chronic rejection among renal and cardiac transplant patients.
Publications
-
From hero to zero: A single center retrospective review of the utility of routine physical crossmatching.
Am J Transplant Volume: 25 Page(s): 1264 - 1273
06/01/2025 Authors: Achram R; Morris AB; Patel L; Bray RA; Gebel HM; Sullivan HC -
Antigen quantity is responsible for the discrepancy between phenotype and single antigen beads for the detection of human leukocyte antigen DQ antibody: Potential clinical implications.
Am J Transplant
04/12/2025 Authors: Shih NR; Nong T; Bray RA; Murphey C; Skaljic I; Gebel HM; Lopez-Cepero M; Nickerson PW; Lee J-H -
Hiding in plain sight: Misinterpretation of immunogenic DPB epitopes within G/P groups.
Hum Immunol Volume: 85 Page(s): 111115
11/01/2024 Authors: Morris AB; Achram R; Cliff Sullivan H; Gebel HM; Bray RA -
Mitigating the Prozone-Like Effect in HLA Antibody Testing: A Case Report of Therapeutic Plasma Exchange for Antibody-Mediated Rejection Post-Heart Transplantation.
J Clin Apher Volume: 39 Page(s): e22144
10/01/2024 Authors: Grewal SK; Achram R; Nakahara H; Roback JD; Morris AB; Gebel HM; Bray RA; Sullivan HC -
Summary of a consensus conference on heart-liver transplantation.
Am J Transplant Volume: 24 Page(s): 380 - 390
03/01/2024 Authors: Kobashigawa J; VanWagner LB; Hall S; Emamaullee J; Entwistle JW; Ganger D; Gebel H; Jeevanandam V; Kaldas F; Kilic A -
The Virtual Crossmatch: What's in a Name?
Transplantation Volume: 107 Page(s): e273
10/01/2023 Authors: Bray RA; Morris AB; Sullivan HC; Gebel HM -
Detailed Analysis of Simultaneous Renal and Liver Allografts in the Presence of DSA.
Transplant Direct Volume: 9 Page(s): e1500
08/01/2023 Authors: O'Leary JG; Farris AB; Gebel HM; Asrani SK; Askar M; Garcia V; Snipes GJ; Lo DJ; Knechtle SJ; Klintmalm GB -
A Primer on Chimerism Analysis: A Straightforward, Thorough Review.
Lab Med Volume: 54 Page(s): 352 - 362
07/05/2023 Authors: Morris AB; Bray R; Gebel HM; Cliff Sullivan H -
Corrigendum to 'Sensitization in transplantation: Assessment of Risk 2022 Working Group Meeting Report' [American Journal of Transplantation 23 (2023) 133-149].
Am J Transplant Volume: 23 Page(s): 694
05/01/2023 Authors: Tambur AR; Bestard O; Campbell P; Chong AS; Crespo M; Ford ML; Gebel HM; Heidt S; Hickey M; Jackson A -
COVID-19 infection and vaccination rarely impact HLA antibody profile in waitlisted renal transplant candidates- a multicenter cohort.
Hum Immunol Volume: 84 Page(s): 278 - 285
04/01/2023 Authors: Roll GR; Bray RA; Cooper M; Eagar TN; Gebel HM; Vranic GM; Hitchman KMK; Houp J; Kamoun M; Killian J -
Clinical recommendations for posttransplant assessment of anti-HLA (Human Leukocyte Antigen) donor-specific antibodies: A Sensitization in Transplantation: Assessment of Risk consensus document.
Am J Transplant Volume: 23 Page(s): 115 - 132
01/01/2023 Authors: Lefaucheur C; Louis K; Morris AB; Taupin J-L; Nickerson P; Tambur AR; Gebel HM; Reed EF; STAR 2022 Working Group -
Sensitization in transplantation: Assessment of Risk 2022 Working Group Meeting Report.
Am J Transplant Volume: 23 Page(s): 133 - 149
01/01/2023 Authors: Tambur AR; Bestard O; Campbell P; Chong AS; Barrio MC; Ford ML; Gebel HM; Heidt S; Hickey M; Jackson A -
Loss of heterozygosity leading to incorrect HLA typing for platelet-transfusion refractory patient.
Volume: 63 Page(s): 263 - 268
01/01/2023 Authors: Horwath M; Tvrdik T; Saxe D; Deeb KK; Roback JD; Gebel HM; Bray RA; Sullivan HC -
Development of donor specific antibodies after SARS-CoV-2 vaccination in kidney and heart transplant recipients.
Transpl Immunol Volume: 75 Page(s): 101722
12/01/2022 Authors: McCune TR; Bray RA; Baran DA; Toepp AJ; Forte SJ; Gilgannon LT; Williams T; Chen S; Sadr H; Gebel HM -
ABO-adjusted calculated panel reactive antibody (cPRA): A unified metric for immunologic compatibility in kidney transplantation.
Am J Transplant Volume: 22 Page(s): 3093 - 3100
12/01/2022 Authors: Gragert L; Kadatz M; Alcorn J; Stewart D; Chang D; Gill J; Liwski R; Gebel HM; Gill J; Lan JH -
Analysis of Cross-sectional and Longitudinal HLA and Anti-viral Responses After COVID Infection in Renal Allograft Recipients: Differences and Correlates.
Transplantation Volume: 106 Page(s): 2085 - 2091
10/01/2022 Authors: Girnita AL; Wang L; Colovai AI; Ahearn P; Azzi Y; Menon MC; Fernandez-Vina M; Gebel HM; Steve Woodle E; Cravedi P -
COVID-19 Infection Does Not Alter HLA Antibody Reactivity.
Kidney Int Rep Volume: 7 Page(s): 2279 - 2282
10/01/2022 Authors: Johnson AC; Larsen CP; Gebel H; Bray R -
Implementing virtual crossmatch based diagnostic management teams in human leukocyte antigen laboratories and transplant programs.
Transpl Immunol Volume: 73 Page(s): 101629
08/01/2022 Authors: Wade J; Roback JD; Krummey SM; Gebel HM; Bray RA; Sullivan HC -
Immunogenicity after heterologous third dose COVID-19 vaccination in a heart transplant recipient.
Clin Transplant Volume: 36 Page(s): e14605
04/01/2022 Authors: Mehta SA; Reyentovich A; Montgomery RA; Segev DL; Gebel HM; Bray RA; Samanovic MI; Cornelius AR; Mulligan MJ; Herati RS -
HLA antigens to epitopes: Meeting the challenge.
Hum Immunol Volume: 83 Page(s): 270 - 271
03/01/2022 Authors: Norin AJ; Gebel HM; Kamoun M -
From antigens to eplets: The evolution of HLA.
Hum Immunol Volume: 83 Page(s): 197 - 198
03/01/2022 Authors: Gebel HM; Norin AJ; Bray RA -
hlaR: A rapid and reproducible tool to identify eplet mismatches between transplant donors and recipients.
Hum Immunol Volume: 83 Page(s): 248 - 255
03/01/2022 Authors: Johnson AC; Zhang J; Cliff Sullivan H; Wiebe C; Bray R; Gebel H; Larsen CP -
Dissecting the impact of molecular T-cell HLA mismatches in kidney transplant failure: A retrospective cohort study.
Front Immunol Volume: 13 Page(s): 1067075
01/01/2022 Authors: Lemieux W; Fleischer D; Yang AY; Niemann M; Oualkacha K; Klement W; Richard L; Polychronakos C; Liwski R; Claas F -
Belatacept in Kidney Transplant Recipients With Failed Allografts for the Prevention of Humoral Sensitization: A Pilot Randomized Controlled Trial.
Transplantation Volume: 105 Page(s): e395 - e396
12/01/2021 Authors: Badell IR; Bray RA; Elbein R; Chami AS; Easley KA; Pastan SO; Guasch A; Gebel HM; Adams AB; Larsen CP -
Delayed Kinetics of IgG, but Not IgA, Antispike Antibodies in Transplant Recipients following SARS-CoV-2 Infection.
J Am Soc Nephrol Volume: 32 Page(s): 3221 - 3230
12/01/2021 Authors: Cravedi P; Ahearn P; Wang L; Yalamarti T; Hartzell S; Azzi Y; Menon MC; Jain A; Billah M; Fernandez-Vina M -
Eplet mismatch imputation studies should include immunologic risk assessment.
Am J Transplant Volume: 21 Page(s): 3500 - 3501
10/01/2021 Authors: Krummey SM; Bray RA; Gebel HM; Sullivan HC -
SARS-CoV-2 Vaccination, Immune Responses, and Antibody Testing in Immunosuppressed Populations: Tip of the Iceberg.
Transplantation Volume: 105 Page(s): 1911 - 1913
09/01/2021 Authors: Woodle ES; Gebel HM; Montgomery RA; Maltzman JS -
On Path to Informing Hierarchy of Eplet Mismatches as Determinants of Kidney Transplant Loss.
Kidney Int Rep Volume: 6 Page(s): 1567 - 1579
06/01/2021 Authors: Mohammadhassanzadeh H; Oualkacha K; Zhang W; Klement W; Bourdiec A; Lamsatfi J; Yi Y; Foster B; Keown P; Gebel HM -
High-throughput sequencing defines donor and recipient HLA B-cell epitope frequencies for prospective matching in transplantation.
Commun Biol Volume: 4 Page(s): 583
05/14/2021 Authors: Tran JN; Gnther OP; Sherwood KR; Fenninger F; Allan LL; Lan J; Sapir-Pichhadze R; Duquesnoy R; Claas F; Marsh SGE -
Hurts So Good: Uncovering the Relationship Between Blood Transfusions and Allograft Outcome.
Kidney Int Rep Volume: 6 Page(s): 875 - 877
04/01/2021 Authors: Sullivan HC; Gebel HM -
Borrowing from the past to invest in the future: The AJT editorial fellowship process.
Am J Transplant Volume: 21 Page(s): 1343 - 1344
03/01/2021 Authors: Adam BA; Gebel HM -
Pretransplant Calculated Panel Reactive Antibody in the Absence of Donor-Specific Antibody and Kidney Allograft Survival.
Clin J Am Soc Nephrol Volume: 16 Page(s): 275 - 283
02/08/2021 Authors: Lan JH; Kadatz M; Chang DT; Gill J; Gebel HM; Gill JS -
Development and Validation of a Multiplex, Bead-based Assay to Detect Antibodies Directed Against SARS-CoV-2 Proteins.
Transplantation Volume: 105 Page(s): 79 - 89
01/01/2021 Authors: Bray RA; Lee J-H; Brescia P; Kumar D; Nong T; Shih R; Woodle ES; Maltzman JS; Gebel HM -
The utility of second single antigen bead assay: Clearing the water or stirring up mud?
Hum Immunol Volume: 81 Page(s): 663 - 670
12/01/2020 Authors: Sullivan HC; Krummey SM; Gebel HM; Bray RA -
IgE in Antibody-Mediated Rejection: A Novel Pathogenic Mechanism?
Clin J Am Soc Nephrol Volume: 15 Page(s): 1392 - 1393
10/07/2020 Authors: Adam BA; Gebel HM -
Investigating complement mediated interference in class I HLA-specific antibodies following renal transplantation.
Transpl Immunol Volume: 62 Page(s): 101310
10/01/2020 Authors: Goldsmith P; Lowe D; Wong C; Howse M; Ridgway D; Hammad A; Mehra S; Christmas S; Gebel H; Bray R -
Sensitization in transplantation: Assessment of risk (STAR) 2019 Working Group Meeting Report.
Am J Transplant Volume: 20 Page(s): 2652 - 2668
10/01/2020 Authors: Tambur AR; Campbell P; Chong AS; Feng S; Ford ML; Gebel H; Gill RG; Kelsoe G; Kosmoliaptsis V; Mannon RB -
Physical Crossmatching vs Virtual Crossmatching: The end of an era? or Why give up a good thing?
Hum Immunol Volume: 81 Page(s): 401 - 406
08/01/2020 Authors: Clifford Sullivan H; Krummey SM; Gebel HM; Bray RA; Jackson AM -
A simple electronic tool for assessing amino acid sequence polymorphisms within exon-2 of HLA-DPB1 alleles.
Hum Immunol Volume: 81 Page(s): 430 - 436
08/01/2020 Authors: Sullivan HC; Gragert L; Smith GH; Lindblad K; Gebel HM; Bray RA -
Epitopes as characterized by antibody-verified eplet mismatches determine risk of kidney transplant loss.
Kidney Int Volume: 97 Page(s): 778 - 785
04/01/2020 Authors: Sapir-Pichhadze R; Zhang X; Ferradji A; Madbouly A; Tinckam KJ; Gebel HM; Blum D; Marrari M; Kim SJ; Fingerson S -
The impact of belatacept on third-party HLA alloantibodies in highly sensitized kidney transplant recipients.
Am J Transplant Volume: 20 Page(s): 573 - 581
02/01/2020 Authors: Parsons RF; Zahid A; Bumb S; Decker H; Sullivan HC; Eun-Hyung Lee F; Badell IR; Ford ML; Larsen CP; Pearson TC -
Identification of a recurrent pattern of false-positivity by Luminex HLA MHC class I single antigen bead testing.
Hum Immunol Volume: 81 Page(s): 73 - 78
01/01/2020 Authors: Dean CL; Krummey SM; Gebel HM; Bray RA; Sullivan HC -
Out with the old, in with the new: Virtual versus physical crossmatching in the modern era.
HLA Volume: 94 Page(s): 471 - 481
12/01/2019 Authors: Morris AB; Sullivan HC; Krummey SM; Gebel HM; Bray RA -
The impact of transfused blood products on deceased donor HLA typing.
Hum Immunol Volume: 80 Page(s): 976 - 982
12/01/2019 Authors: Jacob RP; Dean CL; Krummey SM; Shah Z; Sutherland N; Orear C; Gebel HM; Bray RA; Sullivan HC -
A diagnostic 'C' saw: the ups and downs of C1q testing.
Curr Opin Organ Transplant Volume: 24 Page(s): 402 - 410
08/01/2019 Authors: Gebel HM; Bray RA -
Getting on target: Development of the novel, prozone-resistant, dual antibody rapid test (DART) for the LABScreen single antigen bead (SAB) assay.
Hum Immunol Volume: 80 Page(s): 468 - 477
07/01/2019 Authors: Greenshields A; Bray RA; Gebel HM; Liwski RS -
Impact of HLA-DR Matching on HLA-DQ Matching Status and the Development of Anti-HLA-DQ De Novo DSA under Calcineurin Inhibitor or Belatacept Immunosuppression.
Volume: 19 Page(s): 699 - 700
04/01/2019 Authors: Jucaud V; Gebel H; Bray R; Polinsky M; Everly M -
Mismatched Epitope and De Novo DSA Development: An Analysis of the Benefit and Benefit-EXT Renal Transplant Cohorts.
Volume: 19 Page(s): 384 - 384
04/01/2019 Authors: Jucaud V; Burnett V; Gebel H; Bray R; Polinsky M; Everly M -
Reduction of Pre-Existing Alloantibodies in Highly Sensitized Belatacept-Treated Kidney Recipients.
Volume: 19 Page(s): 810 - 810
04/01/2019 Authors: Parsons RF; Bumb S; Decker H; Zahid A; Sullivan C; Pearson T; Larsen C; Levine M; Kamoun M; Bray RA -
Incidence of De Novo Donor Specific Antibodies and Treatment Response for AMR in Pediatric Kidney Transplant Recipients
Volume: 19 Page(s): 1065 - 1066
04/01/2019 Authors: Gattis S; Liverman R; Serluco A; Yin J; Sullivan HC; Bray RA; Gebel HM; Jernigan S; George R; Winterberg PD -
Belatacept Monotherapy in Kidney Transplant Recipients with Failed Allografts Reduces Humoral Sensitization in a Single Center Randomized Controlled Trial.
AMERICAN JOURNAL OF TRANSPLANTATION Volume: 19 Page(s): 450 - 450
04/01/2019 Authors: Badell IR; Elbein R; Bray RA; Gebel HM; Adams AB; Larsen CP -
Severe Arteritis in Kidney Allografts (Banff v2 to v3 arteritis): Clinicopathologic Correlations
Volume: 32
03/01/2019 Authors: Farris A; Ellis C; Rogers T; Sullivan H; Gebel H; Bray R; Vasanth P -
Severe Arteritis in Kidney Allografts (Banff v2 to v3 arteritis): Clinicopathologic Correlations
Volume: 99
03/01/2019 Authors: Farris A; Ellis C; Rogers T; Sullivan H; Gebel H; Bray R; Vasanth P -
Kidney Allograft Chronic Active Inflammation/Rejection: Analysis of Banff ti and i-IFTA Lesions in the Context of Contemporary Biopsies
Volume: 99
03/01/2019 Authors: Farris A; Ellis C; Rogers T; Sullivan H; Gebel H; Bray R; Vasanth P -
Kidney Allograft Chronic Active Inflammation/Rejection: Analysis of Banff ti and i-IFTA Lesions in the Context of Contemporary Biopsies
Volume: 32
03/01/2019 Authors: Farris A; Ellis C; Rogers T; Sullivan H; Gebel H; Bray R; Vasanth P -
ERRATUM.
Transfusion Volume: 59 Page(s): 827
02/01/2019 -
Stability of anti-A blood group titers among blood group B renal transplant candidates.
Transfusion Volume: 58 Page(s): 2747 - 2751
12/01/2018 Authors: Jacob RP; Dean CL; Krummey SM; Goodman AL; Roback JD; Gebel HM; Bray RA; Sullivan HC -
Evidence of Chronic Allograft Injury in Liver Biopsies From Long-term Pediatric Recipients of Liver Transplants.
Gastroenterology Volume: 155 Page(s): 1838 - 1851.e7
12/01/2018 Authors: Feng S; Bucuvalas JC; Demetris AJ; Burrell BE; Spain KM; Kanaparthi S; Magee JC; Ikle D; Lesniak A; Lozano JJ -
A NOVEL REACTIVITY PATTERN WITH LABSCREENN (TM) CLASS I SINGLE ANTIGEN BEADS AND ITS PREVALENCE AMONG SLE PATIENTS
Volume: 79 Page(s): 15 - 15
10/01/2018 Authors: Dean CL; Bray RA; Gebel HM; Sullivan HC -
RACIAL INEQUITY AMONG 0-ABDR MISMATCHED KIDNEY RECIPIENTS
Volume: 79 Page(s): 48 - 48
10/01/2018 Authors: Bray RA; Gebel HM -
EFFECT OF LEUKOREDUCTION OF TRANSFUSED BLOOD PRODUCTS ON DECEASED DONOR HLA TYPING
Volume: 79 Page(s): 126 - 126
10/01/2018 Authors: Sullivan HC; Krummey SM; Dean C; Shah Z; Sutherland N; Bray RA; Gebel HM -
CHARACTERISTICS OF TRANSPLANT CANDIDATES WITH CPRA >= 99.95% LIKELY TO BE ALLOCATED ORGANS FROM DECEASED DONORS
Volume: 79 Page(s): 17 - 17
10/01/2018 Authors: Parsons R; Decker H; Patzer R; Bumb S; Sullivan HC; Bray RA; Gebel HM -
HLA EPITOPE-MISMATCH MORE PRECISELY PREDICTS THE DEVELOPMENT OF DE NOVO DONOR SPECIFIC ANTIBODY AND ACUTE CELLULAR REJECTION AFTER LUNG TRANSPLANT
Volume: 79 Page(s): 21 - 22
10/01/2018 Authors: Zhang A; Stopczynski N; Thomas D; Sun Y; McMichael J; Kawczak P; Allen J; Budev M; Bray RA; Gebel H -
Prevalence of HLA-Alloantibodies in a Cohort of Men Who Have Sex with Men
Volume: 58 Page(s): 242A - 242A
10/01/2018 Authors: Sullivan H; Kelley CF; Dean CL; Sullivan PS; Biswas S; Roback JD; Bray RA; Gebel HM -
(F)Utility of the physical crossmatch for living donor evaluations in the age of the virtual crossmatch.
Hum Immunol Volume: 79 Page(s): 711 - 715
10/01/2018 Authors: Sullivan HC; Dean CL; Liwski RS; Biswas S; Goodman AL; Krummey S; Gebel HM; Bray RA -
Comparison of de novo IgM and IgG anti-HLA DSAs between belatacept- and calcineurin-treated patients: An analysis of the BENEFIT and BENEFIT-EXT trial cohorts.
Am J Transplant Volume: 18 Page(s): 2305 - 2313
09/01/2018 Authors: Everly MJ; Roberts M; Townsend R; Bray RA; Gebel HM -
De novo donor-specific antibodies in belatacept-treated vs cyclosporine-treated kidney-transplant recipients: Post hoc analyses of the randomized phase III BENEFIT and BENEFIT-EXT studies.
Am J Transplant Volume: 18 Page(s): 1783 - 1789
07/01/2018 Authors: Bray RA; Gebel HM; Townsend R; Roberts ME; Polinsky M; Yang L; Meier-Kriesche H-U; Larsen CP -
Posttransplant reduction in preexisting donor-specific antibody levels after belatacept- versus cyclosporine-based immunosuppression: Post hoc analyses of BENEFIT and BENEFIT-EXT.
Am J Transplant Volume: 18 Page(s): 1774 - 1782
07/01/2018 Authors: Bray RA; Gebel HM; Townsend R; Roberts ME; Polinsky M; Yang L; Meier-Kriesche H-U; Larsen CP -
Sensitization in Transplantation: Assessment of Risk (STAR) 2017 Working Group Meeting Report.
Am J Transplant Volume: 18 Page(s): 1604 - 1614
07/01/2018 Authors: Tambur AR; Campbell P; Claas FH; Feng S; Gebel HM; Jackson AM; Mannon RB; Reed EF; Tinckam K; Askar M -
Identifying Patients with CPRA > 99.95% Likely to Be Offered Deceased Donor Kidneys.
Volume: 18 Page(s): 982 - 982
06/01/2018 Authors: Parsons R; Bumb S; Decker H; Bray R; Gebel H -
Epitope/Eplet Mismatch in Pediatric Renal Transplantation and Development of Donor Specific Antibody.
Volume: 18 Page(s): 267 - 267
06/01/2018 Authors: George R; Sullivan H; Garro R; Winterberg P; Warshaw B; Gebel H; Bray R -
Increasing the Donor Pool for Highly Sensitized Patients with Allele Specific Antibodies: Optimizing the Virtual Crossmatch (vXM).
Volume: 18 Page(s): 445 - 445
06/01/2018 Authors: Zhang A; Zaky Z; Africa J; Good D; Bray R; Gebel H -
Immunogenic HLA Mismatches and Evidence That Belatacept May Be the First Therapy Able to Prevent DQ De Novo DSA: An Analysis of the BENEFIT and BENEFIT-EXT Trial Cohorts.
Volume: 18 Page(s): 780 - 780
06/01/2018 Authors: Everly M; Jucaud V; Roberts M; Gebel H; Bray R -
Determining the Relative Immunogenicity of HLA Mismatches with Calcineurin Inhibitor Immunosuppression: An Analysis of the BENEFIT and BENEFIT-EXT Renal Transplant Cohort.
Volume: 18 Page(s): 289 - 290
06/01/2018 Authors: Jucaud V; Roberts M; Gebel H; Bray R; Everly M -
Racial differences in the development of de-novo donor-specific antibodies and treated antibody-mediated rejection after heart transplantation.
J Heart Lung Transplant Volume: 37 Page(s): 503 - 512
04/01/2018 Authors: Cole RT; Gandhi J; Bray RA; Gebel HM; Yin M; Shekiladze N; Young A; Grant A; Mahoney I; Laskar SR -
Banff Renal Allograft v2 Arteritis: Heterogeneous Clinicopathologic Entity Confirmable by Morphometry Representing Acute Cellular Rejection, Type IIB or not IIB?
Volume: 98 Page(s): 609 - 610
03/01/2018 Authors: Farris AB; Ellis CL; Sullivan H; Bray RA; Gebel H; Rogers TE; Vasanth P -
Transplant Glomerulopathy in the Contemporary Immunosuppression Era: Clues to a Diverse Pathogenesis, Including Etiologies Other Than Donor Specific Antibody
Volume: 98 Page(s): 610 - 610
03/01/2018 Authors: Farris AB; Ellis CL; Sullivan H; Bray RA; Gebel H; Rogers TE; Vasanth P -
Banff Renal Allograft v2 Arteritis: Heterogeneous Clinicopathologic Entity Confirmable by Morphometry Representing Acute Cellular Rejection, Type IIB or not IIB?
Volume: 31 Page(s): 609 - 610
03/01/2018 Authors: Farris AB; Ellis CL; Sullivan H; Bray RA; Gebel H; Rogers TE; Vasanth P -
Transplant Glomerulopathy in the Contemporary Immunosuppression Era: Clues to a Diverse Pathogenesis, Including Etiologies Other Than Donor Specific Antibody
Volume: 31 Page(s): 610 - 610
03/01/2018 Authors: Farris AB; Ellis CL; Sullivan H; Bray RA; Gebel H; Rogers TE; Vasanth P -
POST-TRANSPLANT REDUCTION IN PRE-EXISTING DONOR-SPECIFIC ANTIBODY LEVELS AFTER BELATACEPT-VS CYCLOSPORINE-BASED IMMUNOSUPPRESSION
Volume: 31 Page(s): 20 - 21
01/01/2018 Authors: Bray R; Gebel H; Townsend R; Polinsky M; Yang L; Meier-Kriesche U; Larsen C -
Of Cells and Microparticles: Assets and Liabilities of HLA Antibody Detection.
Transplantation Volume: 102 Page(s): S1 - S6
01/01/2018 Authors: Liwski RS; Gebel HM -
Rapid optimized flow cytometric crossmatch (FCXM) assays: The Halifax and Halifaster protocols.
Hum Immunol Volume: 79 Page(s): 28 - 38
01/01/2018 Authors: Liwski RS; Greenshields AL; Conrad DM; Murphey C; Bray RA; Neumann J; Gebel HM -
Becoming a chef in the human leukocyte antigen kitchen: interpretation and modification of human leukocyte antigen-antibody assays.
Curr Opin Organ Transplant Volume: 22 Page(s): 407 - 414
08/01/2017 Authors: Liwski RS; Greenshields AL; Bray RA; Gebel HM -
The Road to HLA Antibody Evaluation: Do Not Rely on MFI.
Am J Transplant Volume: 17 Page(s): 1455 - 1461
06/01/2017 Authors: Sullivan HC; Liwski RS; Bray RA; Gebel HM -
De novo DQ donor-specific antibodies are associated with worse outcomes compared to non-DQ de novo donor-specific antibodies following heart transplantation.
Volume: 31
04/01/2017 Authors: Cole RT; Gandhi J; Bray RA; Gebel HM; Morris A; McCue A; Yin M; Laskar SR; Book W; Jokhadar M -
Reduced Conversion from IgM Anti-HLA-DSA to IgG Anti-HLA-DSA in Belatacept-Treated vs. Cyclosporine-Treated Patients in BENEFIT and BENEFIT-EXT Trials
Volume: 17 Page(s): 266 - 267
04/01/2017 Authors: Everly M; Townsend R; Gebel H; Bray R -
Post-Transplant Reduction in Pre-Existing Donor-Specific Antibody Levels After Belatacept-vs Cyclosporine-Based Immunosuppression
Volume: 17 Page(s): 267 - 268
04/01/2017 Authors: Bray R; Gebel H; Townsend R; Polinsky M; Yang L; Meier-Kriesche U; Larsen C -
Even with National Sharing, the Prospects of a 100% Sensitized Patient Receiving a Transplant Vary Dramatically Depending on the Precise CPRA Value
Volume: 17 Page(s): 243 - 243
04/01/2017 Authors: Stewart D; Kucheryavaya A; Tyan D; Gebel H; Bray R; Turgeon N -
Genotyping Applications for Transplantation and Transfusion Management: The Emory Experience.
Arch Pathol Lab Med Volume: 141 Page(s): 329 - 340
03/01/2017 Authors: Fasano RM; Sullivan HC; Bray RA; Gebel HM; Meyer EK; Winkler AM; Josephson CD; Stowell SR; Sandy Duncan A; Roback JD -
The new KAS: It takes a village.
Hum Immunol Volume: 78 Page(s): 1 - 3
01/01/2017 Authors: Gebel HM; Kamoun M -
HLA compatibility assessment and management of highly sensitized patients under the new kidney allocation system (KAS): A 2016 status report from twelve HLA laboratories across the U.S.
Hum Immunol Volume: 78 Page(s): 19 - 23
01/01/2017 Authors: Kamoun M; Phelan D; Noreen H; Marcus N; Klingman L; Gebel HM -
GETTING ON TARGET: DEVELOPMENT OF THE NOVEL, PROZONE-RESISTANT, DUAL ANTIBODY RAPID TEST (DART) FOR THE LABSCREEN SINGLE ANTIGEN BEAD (SAB) ASSAY
Volume: 78 Page(s): 70 - 70
01/01/2017 Authors: Greenshields AL; Bray RA; Gebel HM; Liwski RS -
FACTORS THA IMPACT DOWNREGULATION OF HLA ANTIBODIES IN HEART TRANSPLANT CANDIDATES
Volume: 78 Page(s): 96 - 96
01/01/2017 Authors: Ingemi A; McRacken T; Herre J; Bray RA; Gebel HM -
VIRTUAL CROSSMATCHING SUCCESSFULLY EXTENDED DONOR POOL FOR HIGHLY SENSITIZED PATIENTS WITH ALLELE SPECIFIC ANTIBODIES
Volume: 78 Page(s): 125 - +
01/01/2017 Authors: Zhang A; Zaky Z; Africa J; Good D; Walendzik A; Sun Y; Bray R; Gebel HM -
UTILITY OF THE VIRTUAL CROSSMATCH FOR LIVING DONOR EVALUATIONS
Volume: 78 Page(s): 168 - 168
01/01/2017 Authors: Sullivan HC; Dean CL; Goodman AL; Bray RA; Gebel HM -
REMOVAL OF SELECTED NON-SPECIFIC REACTIVITY IN SINGLE ANTIGEN BEAD ASSAYS VIA FBS PRE-TREATMENT
Volume: 78 Page(s): 65 - 65
01/01/2017 Authors: Waslaske SH; McPherson EM; Gebel HM; Bray RA -
STABILITY OF ANTI-A2 BLOOD GROUP SUBTYPE TITERS AMONG BLOOD GROUP B CANDIDATES
Volume: 78 Page(s): 88 - 88
01/01/2017 Authors: Sullivan HC; Dean CL; Krummey SM; Jacob RP; Goodman AL; Gebel HM; Bray RA -
Understanding solid-phase HLA antibody assays and the value of MFI.
Hum Immunol Volume: 78 Page(s): 471 - 480
01/01/2017 Authors: Sullivan HC; Gebel HM; Bray RA -
It's about time: The development and validation of a rapid optimized single antigen bead (ROB) assay protocol for LABScreen.
Hum Immunol Volume: 78 Page(s): 489 - 499
01/01/2017 Authors: Liwski RS; Greenshields AL; Murphey C; Bray RA; Gebel HM -
Kidney Transplantation of the Highly Sensitized Candidate: So Close But So Far Away
Volume: 17 Page(s): 51 - 51
01/01/2017 Authors: Parsons R; Decker H; Gebel H; Bray R -
The new KAS: Challenges and opportunities.
Hum Immunol Volume: 78 Page(s): 54 - 56
01/01/2017 Authors: Gebel HM; Kamoun M -
REDUCED INCIDENCE AND LEVEL OF DE NOVO DONOR-SPECIFIC ANTIBODIES IN BELATACEPT-TREATED VS. CYCLOSPORINE-TREATED PATIENTS: FINAL RESULTS FROM BENEFIT
TRANSPLANT INTERNATIONAL Volume: 29 Page(s): 11 - 12
10/01/2016 Authors: Bray R; Gebel H; Townsend R; Polinsky M; Yang L; Meier-Kriesche U; Larsen C -
Factors associated with successful downregulation of anti-HLA antibodies in heart transplant candidates.
Volume: 36 Page(s): E126 - E126
07/01/2016 Authors: Ellis M; Ingemi A; Palmer B; McRacken T; Landsheft H; Gebel H; Bray R -
A Pathway to Belatacept Monotherapy: Alemtuzumab, Belatacept and Rapamycin for Kidney Transplantation.
Volume: 16 Page(s): 303 - 303
06/01/2016 Authors: Guasch A; Xu H; Mehta A; Ghali A; Mead S; Gebel H; Bray R; Larsen C; Pearson T; Kirk A -
Reduced Incidence and Level of De Novo Donor-Specific Antibodies in Belatacept-Treated vs. Cyclosporine-Treated Patients: Final Results from BENEFIT.
Volume: 16 Page(s): 742 - 742
06/01/2016 Authors: Bray R; Gebel H; Townsend R; Polinsky M; Yang L; Meier-Kriesche U; Larsen C -
Do All cPRA 100% Candidates Have Equal Access to Organ Allocation?
Volume: 16 Page(s): 623 - 623
06/01/2016 Authors: Gebel H; Gustafson S; Segev D; Kasiske B; Israni A -
Virtual Crossmatching Under the New KAS: Safely Bypassing a Physical Crossmatch When Allocating Kidneys to Highly Sensitized Candidates.
Volume: 16 Page(s): 624 - 624
06/01/2016 Authors: Bray R; Parsons R; Turgeon N; Gebel H -
Class I and II HLA antibodies in pediatric patients with thalassemia major.
Transfusion Volume: 56 Page(s): 878 - 884
04/01/2016 Authors: Yee MEM; Shah A; Anderson AR; Boudreaux J; Bray RA; Gebel HM; Josephson CD -
Allocating Deceased Donor Kidneys to Candidates with High Panel-Reactive Antibodies.
Clin J Am Soc Nephrol Volume: 11 Page(s): 505 - 511
03/07/2016 Authors: Gebel HM; Kasiske BL; Gustafson SK; Pyke J; Shteyn E; Israni AK; Bray RA; Snyder JJ; Friedewald JJ; Segev DL -
LONG-TERM SURVIVAL OUTCOMES IN BELATACEPT-TREATED VS CYCLOSPORINE-TREATED PATIENTS: FINAL RESULTS FROM BENEFIT-EXT
TRANSPLANT INTERNATIONAL Volume: 29 Page(s): 8 - 8
02/01/2016 Authors: Durrbach A; Bray R; Gebel H; Florman S; Kuypers D; Larsen CP; Pestana JM; Del Carmen Rial M; Rostaing L; Wekerle T -
BELATACEPT-TREATED PATIENTS HAD SUPERIOR GRAFT SURVIVAL COMPARED WITH CYCLOSPORINE-TREATED PATIENTS: FINAL RESULTS FROM BENEFIT
TRANSPLANT INTERNATIONAL Volume: 29 Page(s): 8 - 8
02/01/2016 Authors: Vincenti F; Bray R; Gebel H; Grinyo J; Moal MC; Rice K; Rostaing L; Steinberg S; Meier-Kriesche U; Polinsky M -
CORRELATION BETWEEN FLOWPRA (R) AND LABSCREEN CLASS II SINGLE ANTIGEN BEADS FOR THE DETECTION OF HLA DQB ANTIBODIES: NOT ALL ASSAYS ARE CREATED EQUAL
Volume: 77 Page(s): 125 - 125
01/01/2016 Authors: Brannon P; Sutherland N; Marcus-Freeman N; Gebel H; Bray R -
APOL1 Genotype and Kidney Transplantation Outcomes From Deceased African American Donors.
Transplantation Volume: 100 Page(s): 194 - 202
01/01/2016 Authors: Freedman BI; Pastan SO; Israni AK; Schladt D; Julian BA; Gautreaux MD; Hauptfeld V; Bray RA; Gebel HM; Kirk AD -
APOL1 Genotype and Kidney Transplantation Outcomes From Deceased African American Donors
TRANSPLANTATION Volume: 100 Page(s): 194 - 202
01/01/2016 Authors: Freedman BI; Pastan SO; Israni AK; Schladt D; Julian BA; Gautreaux MD; Hauptfeld V; Bray RA; Gebel HM; Kirk AD -
Long-Term Survival Outcomes in Belatacept-Treated vs. Cyclosporine-Treated Patients: Final Results From BENEFIT-EXT
AMERICAN JOURNAL OF TRANSPLANTATION Volume: 16 Page(s): 45 - 45
01/01/2016 Authors: Florman S; Bray R; Gebel H; Kuypers D; Larsen C; Medina Pestana J; Rial M; Rostaing L; Wekerle T; Grannas G -
Belatacept-Treated Patients Had Superior Graft Survival vs. Cyclosporine-Treated Patients: Final Results From BENEFIT F
AMERICAN JOURNAL OF TRANSPLANTATION Volume: 16 Page(s): 44 - 44
01/01/2016 Authors: Vincenti F; Grinyo J; Bray R; Rostaing L; Bresnahan B; Rice K; Steinberg S; Gebel H; Polinsky M; Meier-Kriesche U -
Belatacept-treated patients had superior graft survival compared with cyclosporine-treated patients: final results from BENEFIT
Volume: 145 Page(s): 10S - 11S
11/12/2015 Authors: Vincenti F; Bray R; Gebel H; Grinyo J; Moal M-C; Rice K; Rostaing L; Steinberg S; Meier-Kriesche U; Polinsky M -
Long-term survival outcomes in belatacept-treated vs cyclosporine-treated patients: final results from BENEFIT-EXT
Volume: 145 Page(s): 41S - 41S
11/12/2015 Authors: Durrbach A; Bray R; Gebel H; Florman S; Kuypers D; Larsen CP; Pestana JM; Del Carmen Rial M; Rostaing L; Wekerle T -
DONOR-SPECIFIC ANTIBODY RATES ACROSS 7 YEARS OF TREATMENT WITH BELATACEPT: FINAL RESULTS FROM BENEFIT
TRANSPLANT INTERNATIONAL Volume: 28 Page(s): 242 - 242
11/01/2015 Authors: Meier-Kriesche H-U; Bray R; Gebel H; Townsend R; Larsen C -
EVALUATION OF DONOR-SPECIFIC ANTIBODIES THROUGH 7 YEARS WITH BELATACEPT: FINAL RESULTS FROM BENEFIT-EXT
TRANSPLANT INTERNATIONAL Volume: 28 Page(s): 82 - 82
11/01/2015 Authors: Meier-Kriesche H-U; Bray R; Gebel H; Townsend R; Larsen C -
High-Resolution HLA Typing for Sensitized Patients: Advances in Medicine and Science Require Us to Challenge Existing Paradigms.
Am J Transplant Volume: 15 Page(s): 2780 - 2781
10/01/2015 Authors: Duquesnoy RJ; Gebel HM; Woodle ES; Nickerson P; Baxter-Lowe LA; Bray RA; Claas FHJ; Eckels DD; Friedewald JJ; Fuggle SV -
LONG-TERM SURVIVAL OUTCOMES IN BELATACEPT-TREATED VS. CYCLOSPORINE-TREATED PATIENTS: FINAL RESULTS FROM BENEFIT-EXT
TRANSPLANT INTERNATIONAL Volume: 28 Page(s): 10 - 10
10/01/2015 Authors: Durrbach A; Bray R; Gebel H; Florman S; Kuypers D; Larsen CP; Pestana JM; del Carmen Rial M; Rostaing L; Wekerle T -
BELATACEPT PATIENTS HAD SUPERIOR GRAFT SURVIVAL COMPARED WITH CYCLOSPORINE PATIENTS: FINAL RESULTS FROM BENEFIT
TRANSPLANT INTERNATIONAL Volume: 28 Page(s): 10 - 10
10/01/2015 Authors: Vincenti F; Bray R; Gebel H; Grinyo J; Moal M-C; Rice K; Rostaing L; Steinberg S; Meier-Kriesche U; Polinsky M -
Tacrolimus to Belatacept Conversion Following Hand Transplantation: A Case Report.
Am J Transplant Volume: 15 Page(s): 2250 - 2255
08/01/2015 Authors: Cendales L; Bray R; Gebel H; Brewster L; Elbein R; Farthing D; Song M; Parker D; Stillman A; Pearson T -
Red blood cell transfusions are associated with HLA class I but not H-Y alloantibodies in children with sickle cell disease.
Br J Haematol Volume: 170 Page(s): 247 - 256
07/01/2015 Authors: Nickel RS; Hendrickson JE; Yee MM; Bray RA; Gebel HM; Kean LS; Miklos DB; Horan JT -
Apolipoprotein L1 gene variants in deceased organ donors are associated with renal allograft failure.
Am J Transplant Volume: 15 Page(s): 1615 - 1622
06/01/2015 Authors: Freedman BI; Julian BA; Pastan SO; Israni AK; Schladt D; Gautreaux MD; Hauptfeld V; Bray RA; Gebel HM; Kirk AD -
Improving Test Utilization for Chimerism Analysis After Hematopoietic Stem Cell Transplantation
Volume: 143 Page(s): A48 - A48
05/01/2015 Authors: Stelton C; Geller R; Waller E; Langston A; Gebel H; Jaye D -
Deceased Donor Kidney Transplantation Without Calcineurin Inhibitors or Steroids
Volume: 15
05/01/2015 Authors: Kirk A; Guasch A; Mead S; Ghali A; Mehta A; Gebel H; Bray R; Larsen C; Pearson T -
Evaluation of Donor-Specific Antibodies Through 7 Years With Belatacept in BENEFIT and BENEFIT-EXT
Volume: 15
05/01/2015 Authors: Bray R; Gebel H; Townsend R; Meier-Kriesche U; Larsen C -
Should HLA mismatch acceptability for sensitized transplant candidates be determined at the high-resolution rather than the antigen level?
Am J Transplant Volume: 15 Page(s): 923 - 930
04/01/2015 Authors: Duquesnoy RJ; Kamoun M; Baxter-Lowe LA; Woodle ES; Bray RA; Claas FHJ; Eckels DD; Friedewald JJ; Fuggle SV; Gebel HM -
IMPORTANCE OF ROUTINE COMPARISONS BETWEEN LUMINEX INSTRUMENTS WITHIN A SINGLE LABORATORY
Volume: 76 Page(s): 87 - 87
01/01/2015 Authors: Muchhala M; Wilmoth-Hosey L; Marcus-Freeman N; Gebel HM; Bray RA -
HLA-DPB1*ANTIGEN FREQUENCIES IN DECEASED DONORS: MINING THE DATA.
Volume: 76 Page(s): 26 - 26
01/01/2015 Authors: Karas A; Marcus-Freeman N; Breitenbach C; McRacken TT; Bray RA; Gebel H -
DIGGING DEEP: IDENTIFICATION OF A HIDDEN CROSSOVER
Volume: 76 Page(s): 86 - 86
01/01/2015 Authors: Weingard P; Marcus-Freeman N; Bray RA; Gebel HM -
ALLELIC ANTIBODIES AND THEIR IMPACT ON ORGAN ALLOCATION TO HIGHLY SENSITIZED PATIENTS
Volume: 76 Page(s): 61 - 61
01/01/2015 Authors: Iwakoshi NN; Bray RA; Gebel HM -
COMPUTER ASSISTED ALGORITHM FOR ASSESSING HLA DPB1 DONOR:RECIPIENT COMPATIBILITY.
Volume: 76 Page(s): 25 - 25
01/01/2015 Authors: Smith GH; Gebel HM; Bray RA -
INCREASED RELIANCE ON THE VIRTUAL CROSSMATCH UNDER THE NEW KIDNEY ALLOCATION SCHEMA (KAS)
Volume: 76 Page(s): 6 - 6
01/01/2015 Authors: Parsons RF; Gebel HM; Turgeon NA; Bray RA -
EVALUATION OF DONOR-SPECIFIC ANTIBODIES THROUGH 5 YEARS WITH BELATACEPT IN BENEFIT AND BENEFIT-EXT
TRANSPLANT INTERNATIONAL Volume: 28 Page(s): 7 - 7
01/01/2015 Authors: Meier-Kriesche U; Bray R; Gebel H; Brannon P; Ganguly B; Townsend R; Harler MB; Larsen C -
The new OPTN kidney allocation policy: potential for inequitable access among highly sensitized patients.
Am J Transplant Volume: 15 Page(s): 284 - 285
01/01/2015 Authors: Bray RA; Brannon P; Breitenbach C; Bryan C; Chen D-F; Lai J; McRacken T; Kirk A; Kaplan B; Pearson T -
The new kidney allocation system (KAS) and the highly sensitized patient: expect the unexpected.
Am J Transplant Volume: 14 Page(s): 2917
12/01/2014 Authors: Bray RA; Gebel HM -
Analysis of graft survival in a trial of stem cell transplant in ALS.
Ann Clin Transl Neurol Volume: 1 Page(s): 900 - 908
11/01/2014 Authors: Tadesse T; Gearing M; Senitzer D; Saxe D; Brat DJ; Bray R; Gebel H; Hill C; Boulis N; Riley J -
What goes around comes around.
Transplantation Volume: 98 Page(s): 817 - 818
10/27/2014 Authors: Gebel HM -
Solid-phase assays for the detection of alloantibody against human leukocyte antigens: panacea or Pandora?
Int J Immunogenet Volume: 41 Page(s): 362 - 369
10/01/2014 Authors: Roberts T; Tumer G; Gebel HM; Bray RA -
HLA antibody detection with solid phase assays: great expectations or expectations too great?
Am J Transplant Volume: 14 Page(s): 1964 - 1975
09/01/2014 Authors: Gebel HM; Bray RA -
Pronase Treatment Reduces Denatured HLA Antigen On Single Antigen Beads (SABs)
Volume: 98 Page(s): 443 - 444
07/15/2014 Authors: Roberts T; Tumer G; Gebel H; Bray R -
Tacrolimus to Belatacept Conversion Following Hand Transplantation: A Case Report.
Volume: 98 Page(s): 410 - 410
07/15/2014 Authors: Cendales L; Bray R; Gebel H; Brewster L; Elbein R; Song M; Parker D; Stillman A; Pearson T; Kirk A -
Evaluation of Donor-Specific Antibodies Through 5 Years With Belatacept in BENEFIT and BENEFIT-EXT.
Volume: 98 Page(s): 117 - 117
07/15/2014 Authors: Bray R; Gebel H; Brannon P; Ganguly B; Townsend R; Meier-Kriesche U; Harler M; Larsen C -
Alemtuzumab, Belatacept and Sirolimus: A Path to Monotherapy Belatacept
Volume: 98 Page(s): 80 - 80
07/15/2014 Authors: Kirk A; Guasch A; Xu H; Cheeseman J; Mead S; Ghali A; Mehta A; Gebel H; Bray R; Horan J -
Pronase Treatment Reduces Denatured HLA Antigen On Single Antigen Beads (SABs)
Volume: 14 Page(s): 443 - 444
06/01/2014 Authors: Roberts T; Tumer G; Gebel H; Bray R -
Evaluation of Donor-Specific Antibodies Through 5 Years With Belatacept in BENEFIT and BENEFIT-EXT
Volume: 14 Page(s): 117 - 117
06/01/2014 Authors: Bray R; Gebel H; Brannon P; Ganguly B; Townsend R; Meier-Kriesche U; Harler M; Larsen C -
Alemtuzumab, Belatacept and Sirolimus: A Path to Monotherapy Belatacept
Volume: 14 Page(s): 80 - 80
06/01/2014 Authors: Kirk A; Guasch A; Xu H; Cheeseman J; Mead S; Ghali A; Mehta A; Gebel H; Bray R; Horan J -
Renal transplantation using belatacept without maintenance steroids or calcineurin inhibitors.
Am J Transplant Volume: 14 Page(s): 1142 - 1151
05/01/2014 Authors: Kirk AD; Guasch A; Xu H; Cheeseman J; Mead SI; Ghali A; Mehta AK; Wu D; Gebel H; Bray R -
The role of donor-specific HLA alloantibodies in liver transplantation.
Am J Transplant Volume: 14 Page(s): 779 - 787
04/01/2014 Authors: O'Leary JG; Demetris AJ; Friedman LS; Gebel HM; Halloran PF; Kirk AD; Knechtle SJ; McDiarmid SV; Shaked A; Terasaki PI -
IT'S ABOUT TIME. THE DEVELOPMENT OF THE RAPID OPTIMIZED SINGLE ANTIGEN BEAD (ROB) LABSCREEN (R) PROTOCOL TO EXPEDITE HLA ANTIBODY TESTING.
Volume: 75 Page(s): 7 - 7
01/01/2014 Authors: Liwski R; Neumann J; Peladeau G; Heinstein K; Sperry R; Bray R; Gebel H -
THE NEW OPTN KIDNEY ALLOCATION POLICY: INEQUITBLE ACCESS AMONG HIGHLY SENSITIZED PATIENTS.
Volume: 75 Page(s): 30 - 30
01/01/2014 Authors: Bray R; Brannon P; Breitenbach C; McRacken T; Stephens M; Lai J; Mui E; Gebel H -
Alloantibodies, Sensitization and Virtual Crossmatching
Page(s): 443 - 451
01/01/2014 Authors: Gebel HM; Bray RA -
Monitoring for HLA Antibody after Organ Transplantation
Page(s): 1059 - 1064
01/01/2014 Authors: Bray RA; Gebel HM -
KEEP IT COOL. A NOVEL INHIBITOR COMPLEX EXCLUSION (ICE) PROTOCOL FOR LABSCREEN THAT PREVENTS THE "PROZONE" EFFECT.
Volume: 75 Page(s): 7 - 7
01/01/2014 Authors: Liwski R; Bray R; Gebel H -
PRONASE TREATMENT OF SINGLE ANTIGEN BEADS (SAB) REVEALS A COMPLEX BIOLOGY FOR EXPLAINING DENATURED HLA ANTIGENS.
Volume: 75 Page(s): 66 - 66
01/01/2014 Authors: Roberts TK; Turner G; Bray RA; Gebel HM -
A BIOTIN/STREPTAVIDIN ENHANCED SINGLE ANTIGEN BEAD (SAB) METHOD IMPROVES SENSITIVITY AND OVERCOMES COMPLEMENT MEDIATED INHIBITION.
Volume: 75 Page(s): 66 - 66
01/01/2014 Authors: Roberts TK; Tinckam K; Turner G; Gebel HM; Bray RA -
Influence of race/ethnic differences in pre-transplantation panel reactive antibody on outcomes in heart transplant recipients.
Volume: 62 Page(s): 2308 - 2315
12/17/2013 Authors: Morris AA; Cole RT; Veledar E; Bellam N; Laskar SR; Smith AL; Gebel HM; Bray RA; Butler J -
Alloimmunization To HLA Class I Antigens But Not H-Y Antigens Is Associated With Transfusion In Children With Sickle Cell Disease
Volume: 122
11/15/2013 Authors: Nickel RS; Hendrickson JE; Kean LS; Yee MEM; Bray RA; Gebel HM; Miklos DB; Horan JT -
Comprehensive assessment and standardization of solid phase multiplex-bead arrays for the detection of antibodies to HLA-drilling down on key sources of variation.
Am J Transplant Volume: 13 Page(s): 3050 - 3051
11/01/2013 Authors: Reed EF; Rao P; Zhang Z; Gebel H; Bray RA; Guleria I; Lunz J; Mohanakumar T; Nickerson P; Tambur AR -
"In Control" in the HLA Laboratory: Using QC to Improve Consistency and Efficiency
Volume: 140 Page(s): 420 - 420
09/01/2013 Authors: Roberts-Wilson TK; Tumer G; Bray RA; Gebel HM; Fantz CR -
Conundrums With Solid Phase HLA Antibody Testing
Volume: 140 Page(s): 420 - 420
09/01/2013 Authors: Tumer G; Roberts-Wilson T; Gebel HM; Bray RA; Hill CE -
Technical aspects of HLA antibody testing.
Curr Opin Organ Transplant Volume: 18 Page(s): 455 - 462
08/01/2013 Authors: Gebel HM; Liwski RS; Bray RA -
In search of perfection.
Am J Transplant Volume: 13 Page(s): 1951 - 1952
08/01/2013 Authors: Gebel HM; Bray RA -
Comprehensive assessment and standardization of solid phase multiplex-bead arrays for the detection of antibodies to HLA.
Am J Transplant Volume: 13 Page(s): 1859 - 1870
07/01/2013 Authors: Reed EF; Rao P; Zhang Z; Gebel H; Bray RA; Guleria I; Lunz J; Mohanakumar T; Nickerson P; Tambur AR -
GOING WITH THE FLOW: CANADIAN EXPERIENCE WITH FLOW CROSSMATCH STANDARDIZATION
Volume: 81 Page(s): 329 - 330
05/01/2013 Authors: Liwski R; Pochinco D; Tinckam K; Gebel H; Campbell P; Nickerson P -
UNEXPLAINED POSITIVE REACTIONS WITH ONE LAMBDA, FLOWPRA (TM) LOT #18
Volume: 74 Page(s): 486 - 486
05/01/2013 Authors: Bray RA; McLachlan L; Chapman P; Marcus N; Gebel HM -
Allocating Deceased Donor Kidneys to High PRA Patients: A Simulation.
Volume: 13 Page(s): 178 - 178
04/01/2013 Authors: Gebel H; Kasiske B; Gustafson S; Shteyn E; Israni A; Snyder J; Friedewald J; Segev D -
HLA-DR Mismatching Is Not Associated with Decreased Graft Survival in Highly Sensitized Kidney Recipients.
Volume: 13 Page(s): 420 - 420
04/01/2013 Authors: Ruhil R; Talebagha S; Beus J; Pearson T; Gebel H; Bray R; Turgeon N -
Class II alloantibody and mortality in simultaneous liver-kidney transplantation.
Am J Transplant Volume: 13 Page(s): 954 - 960
04/01/2013 Authors: O'Leary JG; Gebel HM; Ruiz R; Bray RA; Marr JD; Zhou XJ; Shiller SM; Susskind BM; Kirk AD; Klintmalm GB -
Gradual vs Rapid Withdrawal of Immunosuppression after Kidney Allograft Failure Results in Less Allosensitization, Decreased Rate of De-Novo Donor Specific Antibody and Reduced Need for Allograft Nephrectomy.
Volume: 13 Page(s): 472 - 472
04/01/2013 Authors: Rao S; Bray R; Perez S; Pastan S; Gebel H; Chami A -
Bortezomib Impacts T-Cell Signaling and Regulatory Pathways
Volume: 13 Page(s): 535 - 535
04/01/2013 Authors: Moussa O; Askar M; Gebel H; Flechner S; Taber D; Chavin K; Baliga P; Srinivas T -
Precision diagnostics in transplantation: from bench to bedside.
Volume: 13 Page(s): 562 - 568
03/01/2013 Authors: Mengel M; Campbell P; Gebel H; Randhawa P; Rodriguez ER; Colvin R; Conway J; Hachem R; Halloran PF; Keshavjee S -
Utility of Whole Slide Imaging Algorithms in the Assessment of Renal Allograft Biopsies: Does Automated Analysis Provide a Better Assessment of Donor Specific Antibody Than Human Scoring?
Volume: 93 Page(s): 393A - 394A
02/01/2013 Authors: Stuart LN; Tumer G; Roberts-Wilson T; Gebel HM; Bray RA; Farris AB -
Utility of Whole Slide Imaging Algorithms in the Assessment of Renal Allograft Biopsies: Does Automated Analysis Provide a Better Assessment of Donor Specific Antibody Than Human Scoring?
Volume: 26 Page(s): 393A - 394A
02/01/2013 Authors: Stuart LN; Tumer G; Roberts-Wilson T; Gebel HM; Bray RA; Farris AB -
Consensus guidelines on the testing and clinical management issues associated with HLA and non-HLA antibodies in transplantation.
Transplantation Volume: 95 Page(s): 19 - 47
01/15/2013 Authors: Tait BD; Ssal C; Gebel HM; Nickerson PW; Zachary AA; Claas FHJ; Reed EF; Bray RA; Campbell P; Chapman JR -
QUALITY CONTROL IN THE HLA LABORATORY: THE EFFECT OF INTER-ASSAY VARIABILITY ON SINGLE ANTIGEN BEAD ASSAYS (SABs).
Volume: 74 Page(s): 95 - 95
01/01/2013 Authors: Roberts-Wilson TK; Turner G; Bray RA; Gebel HM -
ONE IS NOT ENOUGH: POTENTIAL IMPACT OF DISCONNECTS BETWEEN SOLID-PHASE ASSAYS.
Volume: 74 Page(s): 168 - 168
01/01/2013 Authors: Roberts-Wilson TK; Turner G; Gebel HM; Bray RA -
FATAL GRAFT VERSUS HOST DISEASE (GVHD) AFTER ZERO MISMATCH KIDNEY/PANCREAS TRANSPLANTATION.
Volume: 74 Page(s): 21 - 21
01/01/2013 Authors: Tumer G; Roberts-Wilson TK; Bray RA; Gebel HM -
THE ANTI-HUMAN GLOBULIN ENHANCED C1QSCREEN (TM) ASSAY IMPROVES THE DETECTION OF COMPLEMENT BINDING DONOR SPECIFIC HLA ANTIBODIES
Volume: 74 Page(s): 48 - 48
01/01/2013 Authors: Liwski R; Lee S; Sperry R; Nickerson P; Bray R; Gebel H -
INTERFERING FACTORS INTERFERE WITH VIRTUAL CROSSMATCH (vXM) INTERPRETATION.
Volume: 74 Page(s): 70 - 70
01/01/2013 Authors: McRacken TT; Keatley K; Stephens M; Hogan K; Spraggins C; Zannini A; Fortes W; Phelps E; Bray RA; Gebel HM -
PRETREATMENT OF PATIENT SERUM WITH FETAL BOVINE SERUM (FBS) REDUCES NON-SPECIFIC BACKGROUND AND ENHANCES HLA ANTIBODY DETECTION IN BEAD AND CELL BASED ASSAYS
Volume: 74 Page(s): 57 - 57
01/01/2013 Authors: Breitenbach C; Kaelin L; Chapman P; Gebel HM; Bray RA -
NO DIRECT CORRELATION BETWEEN DONOR SPECIFIC ANTIBODY (DSA) MEAN FLUORESCENCE INTENSITY (MFI) AND C4d POSITIVITY IN ANTIBODY MEDIATED REJECTION (AMR).
Volume: 74 Page(s): 98 - 98
01/01/2013 Authors: Tumer G; Roberts-Wilson TK; Alton FB; Lauren SN; Gebel HM; Bray RA -
IMPACT OF VARYING MFI THRESHOLDS ON CPRA VALUES AND ACCESS TO DECEASED DONOR ORGANS.
Volume: 74 Page(s): 68 - 68
01/01/2013 Authors: Lai J; Mui E; Eckels D; Gebel H; Bry W; Katznelson S; Patel P; Bray R -
Cross Validation of Luminex Platforms from Two Vendors to Detect and Quantify HLA Antibodies Using Single Antigen Assay Results from 7 CTOT Core Laboratories
Volume: 94 Page(s): 198 - 198
11/27/2012 Authors: Reed E; Rao P; Zhang Z; Gebel H; Bray R; Guleria I; Mohanakumar T; Nickerson P; Tambur A; Zeevi A -
Translational applications of flow cytometry in clinical practice.
J Immunol Volume: 188 Page(s): 4715 - 4719
05/15/2012 Authors: Jaye DL; Bray RA; Gebel HM; Harris WAC; Waller EK -
Revisiting Acceptable Mismatching of HLA Antigens: Transplanting Highly Sensitized Patients
Volume: 12 Page(s): 416 - 416
05/01/2012 Authors: Bray R; Ruhil R; Beus J; Pearson T; Turgeon N; Gebel H -
A Retrospective Analysis of 10 Years of Acceptable Mismatching of HLA Antigens in Deceased Donor Kidney Transplantation
Volume: 12 Page(s): 420 - 421
05/01/2012 Authors: Ruhil R; Beus J; Pearson T; Gebel H; Bray R; Turgeon N -
Preformed MHC Class II Antibodies Increase the Risk of Liver but Not Kidney Rejection after Simultaneous Liver-Kidney Transplant.
Volume: 18 Page(s): S92 - S92
05/01/2012 Authors: O'Leary JG; Gebel HM; Ruiz RM; Bray RA; Marr JD; Susskind BM; Kirk AD; Klintmalm GB -
Preformed MHC Class II DSA Increases the Risk of Liver but Not Kidney Rejection after Simultaneous Liver-Kidney Transplant
Volume: 12 Page(s): 127 - 127
05/01/2012 Authors: O'Leary JG; Gebel HM; Ruiz RM; Marr JD; Susskind BM; Jennings L; Kirk AD; Klintmalm GB -
Validation of the Luminex Platform To Detect and Quantify HLA Antibodies: Assessment of Manufacture Variability by 7 CTOT Core Laboratories
Volume: 12 Page(s): 311 - 311
05/01/2012 Authors: Reed E; Rao P; Zhang Z; Gebel H; Guleria I; Mohanakumar T; Nickerson P; Tambur A; Zeevi A; Gjertson D -
Validation of the Luminex Platform To Detect and Quantify HLA Antibodies: Consistency in Median Florescence Intensity (MFI) among 7 CTOT Core Laboratories
Volume: 12 Page(s): 169 - 169
05/01/2012 Authors: Reed E; Rao P; Zhang Z; Gebel H; Guleria I; Mohanakumar T; Nickerson P; Tambur A; Zeevi A; Gjertson D -
VALIDATION OF THE LUMINEX PLATFORM TO DETECT HLA ANTIBODIES: EFFECT OF STANDARDIZING OPERATION PROCEDURES ON TEST VARIABILITY BY CTOT CORE LABORATORIES
Volume: 73 Page(s): 25 - 25
01/01/2012 Authors: Rao P; Zhang Z; Gebel H; Bray RA; Guleria I; Mohanakumar T; Nickerson P; Tambur A; Zeevi A; Heeger P -
HEAT SENSTIVE "INTERFERING FACTOR" MASKS THE POST TRANSPLANT DETECTION OF DE NOVO DONOR SPECIFIC ANTIBODY
Volume: 73 Page(s): 93 - 93
01/01/2012 Authors: McRacken TT; Spraggins CM; Gebel HM; Bray RA -
Revisiting traditional risk factors for rejection and graft loss after kidney transplantation.
Am J Transplant Volume: 11 Page(s): 2132 - 2143
10/01/2011 Authors: Dunn TB; Noreen H; Gillingham K; Maurer D; Ozturk OG; Pruett TL; Bray RA; Gebel HM; Matas AJ -
KIR-HLA mismatching in human renal allograft transplantation: emergence of a new concept.
Am J Transplant Volume: 11 Page(s): 1771 - 1772
09/01/2011 Authors: Rajalingam R; Gebel HM -
EVALUATION OF DONOR-SPECIFIC ANTIBODIES IN KIDNEY TRANSPLANT PATIENTS TREATED WITH BELATACEPT- OR CYCLOSPORINE-BASED IMMUNOSUPPRESSION IN BENEFIT AND BENEFIT-EXT
TRANSPLANT INTERNATIONAL Volume: 24 Page(s): 69 - 69
09/01/2011 Authors: Larsen CP; Bray R; Gebel H; Ganguly B; Kulbokas E; Brickman D; Duan T; Townsend R -
Antibody-mediated rejection--an ounce of prevention is worth a pound of cure.
Am J Transplant Volume: 11 Page(s): 1131 - 1139
06/01/2011 Authors: Bradley JA; Baldwin WM; Bingaman A; Ellenrieder C; Gebel HM; Glotz D; Kirk AD -
Luminex MFI values do not correlate with flow cytometry crossmatch (FCXM) results in patients with low levels of HLA antibodies directed against the public epitopes BW4 AND BW6
Volume: 77 Page(s): 444 - 444
05/01/2011 Authors: Moussa O; Waslaske SH; Thompson T; Marchman CG; Bray RA; Gebel HM -
Regulatory approval for new antihumoral therapies: addressing the barriers.
Am J Transplant Volume: 11 Page(s): 880 - 881
05/01/2011 Authors: Woodle ES; Gebel HM -
Antibody Mediated Rejection in Kidney Transplant Recipients with and without Donor Specific Antibodies.
Volume: 11 Page(s): 297 - 297
04/01/2011 Authors: Miguel M; Lai J; Bray R; Eckels D; Gebel H; Bry W; Katznelson S; Peddi VR -
Optimization of Flow Cytometric Crossmatch Protocol To Expedite Pre-Transplant Immunologic Risk Assessment.
Volume: 11 Page(s): 473 - 473
04/01/2011 Authors: Liwski RS; Gebel HM -
Donor-directed MHC class I antibody is preferentially cleared from sensitized recipients of combined liver/kidney transplants.
Am J Transplant Volume: 11 Page(s): 841 - 847
04/01/2011 Authors: Dar W; Agarwal A; Watkins C; Gebel HM; Bray RA; Kokko KE; Pearson TC; Knechtle SJ -
HLA-DR Immunohistochemistry Quantitation in Renal Allograft Biopsies: Objective Discrimination of Rejection and Other Pathologic Processes
Volume: 91 Page(s): 344A - 344A
02/01/2011 Authors: Farris AB; Kong J; Chisolm C; Gebel HM; Bray RA; Cohen C; Brat DJ; Saltz JH; Kirk AD; Hennigar R -
HLA-DR Immunohistochemistry Quantitation in Renal Allograft Biopsies: Objective Discrimination of Rejection and Other Pathologic Processes.
Volume: 24 Page(s): 344A - 344A
02/01/2011 Authors: Farris AB; Kong J; Chisolm C; Gebel HM; Bray RA; Cohen C; Brat DJ; Saltz JH; Kirk AD; Hennigar R -
Paired kidney donation: a (virtual) balancing act.
Am J Transplant Volume: 11 Page(s): 194 - 195
02/01/2011 Authors: Bingaman AW; Bray RA; Gebel HM; Newell KA -
Clinical cytometry and progress in HLA antibody detection.
Methods Cell Biol Volume: 103 Page(s): 285 - 310
01/01/2011 Authors: Bray RA; Tarsitani C; Gebel HM; Lee J-H -
AN OPTIMIZED FLOW CYTOMETRIC CROSSMATCH ASSAY EXPEDITES PRE-TRANSPLANT IMMUNOLOGIC RISK ASSESSMENT
Volume: 72 Page(s): S48 - S48
01/01/2011 Authors: Liwski R; Adams G; Peladeau G; Eckels D; Bray R; Gebel H -
PREDICTING CROSSMATCH RESULTS BASED ON LUMINEX MFI VALUES: GREAT EXPECTATIONS OR EXPECTATIONS TOO GREAT?
Volume: 72 Page(s): S32 - S32
01/01/2011 Authors: Gebel HM; Bray RA -
IDENTIFICATION OF DENATURED CLASS II (DRB4) ANTIGENS ON SINGLE ANTIGEN BEADS
Volume: 72 Page(s): S20 - S20
01/01/2011 Authors: Bray RA; Gebel HM; Lee J -
SHOULD CONFIRMATORY HLA TYPING BE MANDATORY?
Volume: 72 Page(s): S151 - S151
01/01/2011 Authors: Breitenbach C; Bray RA; Gebel HM -
SEROLOGICAL EVIDENCE FOR THREE DISTINCT SUB-EPITOPES OF Bw6
Volume: 72 Page(s): S22 - S22
01/01/2011 Authors: Bray RA; Gebel HM -
THE IMPORTANCE OF IDENTIFYING WEAK DSA AT THE TIME OF TRANSPLANT IN THE FACE OF A NEGATIVE CROSSMATCH.
Volume: 72 Page(s): S155 - S155
01/01/2011 Authors: McRacken TT; Bray RA; Gebel HM; Stephens MS; Kalmanovich Y -
SINGLE ANTIGEN BEADS REACH SATURATION AT ANTIBODY LEVELS THAT DO NOT SATURATE LYMPHOCYTES IN THE FLOW CYTOMETRIC CROSSMATCH
Volume: 72 Page(s): S21 - S21
01/01/2011 Authors: Bray RA; Coleman LA; Brannon PE; Gebel HM -
The evolution and clinical impact of human leukocyte antigen technology.
Curr Opin Nephrol Hypertens Volume: 19 Page(s): 598 - 602
11/01/2010 Authors: Gebel HM; Bray RA -
A novel Luminex based detection method for IgG subclass specification of anti-HLA antibodies
Volume: 75 Page(s): 577 - 577
05/01/2010 Authors: Ozturk OG; Bray R; Gebel H -
Impact of Desensitization on Donor Sensitized, AHG XM Negative Kidney Transplants
Volume: 10 Page(s): 225 - 226
04/01/2010 Authors: Dunn TB; Noreen HJ; Maurer D; Ozturk OG; Gillingham K; Bray R; Gebel H; Matas AJ -
Impact of Flow XM Results on Kidney Transplant Outcomes for Recipients with Donor Specific Antibody (DSA).
Volume: 10 Page(s): 236 - 236
04/01/2010 Authors: Dunn TB; Ozturk OG; Noreen H; Maurer D; Gillingham K; Bray RA; Matas AJ; Gebel HM -
HLA alloimmunization is associated with RBC antibodies in multiply transfused patients with sickle cell disease.
Pediatr Blood Cancer Volume: 54 Page(s): 552 - 558
04/01/2010 Authors: McPherson ME; Anderson AR; Castillejo M-I; Hillyer CD; Bray RA; Gebel HM; Josephson CD -
Liver Transplantation Removes MHC Class I but Not Class II Antibody from Sensitized Recipients of Combined Liver/Kidney Transplants.
Volume: 10 Page(s): 100 - 100
04/01/2010 Authors: Agarwal A; Gebel HM; Bray RA; Watkins C; Kokko KE; Pearson TC; Knechtle SJ -
CPRA: Advantage or Disadvantage?
Volume: 10 Page(s): 65 - 66
04/01/2010 Authors: Meier-Kriesche H-U; Gebel H; Gregg JA; Casey MJ; Lodhi S; Rehman S; Scornik J -
Making sense of desensitization.
Am J Transplant Volume: 10 Page(s): 443 - 444
03/01/2010 Authors: Gebel HM; Halloran PF -
DEFINING CUT-OFF FOR THE LUMINEX MFI THAT CAN PREDICT THE FLOW CYTOMETRIC CROSSMATCH (FCXM) RESULTS.
Volume: 71 Page(s): S46 - S46
01/01/2010 Authors: Moussa O; Gebel HM; Bray RA -
DISCONNECT BETWEEN LUMINEX MFI AND FLOW CYTOMETRY CROSSMATCH (FCXM) RESULTS FOR Bw4 AND Bw6 ANTIBODIES.
Volume: 71 Page(s): S145 - S145
01/01/2010 Authors: Moussa O; Waslaski SH; Thompson T; O'Shields AR; Marchman CG; Bray RA; Gebel HM -
PLATELET REFRACTORY PATIENT WITH AN ALLELE SPECIFIC HLA ANTIBODY.
Volume: 71 Page(s): S122 - S122
01/01/2010 Authors: O'Shields AR; Cellars KA; Gates DA; Hagy C; McPherson EM; Thompson TG; Waslaski SH; Moussa O; Gebel HM; Bray RA -
IMPACT OF LOW LEVEL DONOR SPECIFIC ANTIBODIES IN RENAL TRANSPLANT OUTCOMES
Volume: 71 Page(s): S25 - S25
01/01/2010 Authors: Dunn TB; Noreen H; Maurer D; Ozturk OG; Gillingham K; Matas AJ; Bray RA; Gebel HM -
LUMINEX BASED DETECTION OF IgG SUBCLASSES IN HLA ALLOANTISERA
Volume: 71 Page(s): S98 - S98
01/01/2010 Authors: Ozturk OG; Bray RA; Gebel HM -
Proinflammatory events and HLA antibodies: nothing to sneeze at.
Am J Transplant Volume: 9 Page(s): 1971 - 1972
09/01/2009 Authors: Kokko KE; Bray RA; Nickerson PW; Gebel HM -
Strategies for human leukocyte antigen antibody detection.
Curr Opin Organ Transplant Volume: 14 Page(s): 392 - 397
08/01/2009 Authors: Bray RA; Gebel HM -
Donor-reactive HLA antibodies in renal allograft recipients: considerations, complications, and conundrums.
Hum Immunol Volume: 70 Page(s): 610 - 617
08/01/2009 Authors: Gebel HM; Moussa O; Eckels DD; Bray RA -
CANADIAN PROFICIENCY TESTING III - STANDARDIZING LUMINEX Ab DATA IS POSSIBLE
Volume: 70 Page(s): S44 - S44
01/01/2009 Authors: Tinckam K; Campbell P; Eckels D; Bray R; Gebel H; Nickerson P -
CANADIAN PROFICIENCY TESTING III - PROGRESS TOWARD NATIONAL SHARING.
Volume: 70 Page(s): S13 - S13
01/01/2009 Authors: Campbell P; Tinckam K; Bray R; Eckels D; Nickerson P; Gebel H -
Early Results from the Clinical Trials in Organ Transplantation (CTOT-01) Trial Identify Noninvasive Markers as Correlates of 6-Month Renal Allograft Pathology.
Volume: 9 Page(s): 191 - 191
01/01/2009 Authors: Hricik D; Poggio E; Newell K; Rush D; Nickerson P; Formica R; Akalin E; Goebel J; Fairchild R; Gebel H -
ANTIBODY-MEDIATED REJECTION WITH ANTI-HLA-DP ANTIBODIES IN A HLA IDENTICAL RENAL ALLOGRAFT
Volume: 70 Page(s): S142 - S142
01/01/2009 Authors: Halpin A; Sis B; Youngs D; Gebel H; Bray R; Campbell P -
EVALUATION OF THE WHOLE GENOME AMPLIFICATION PROCEDURE IN ROUTINE HLA TYPING OF STEM CELLS TRANSPLANTATION CANDIDATES
Volume: 70 Page(s): S34 - S34
01/01/2009 Authors: Waslaske SH; Gates DA; Nasse CB; Bray RA; Gebel HM; Moussa O -
Positive Cross-Match Kidney Transplantation in a Non-Academic Transplant Program: Is It Feasible?
Volume: 9 Page(s): 561 - 561
01/01/2009 Authors: Pollinger H; Tan M; Wolf J; Johnson M; Sellers M; Cross R; Bray R; Gebel H; Zayas C; Whelchel J -
USE OF THE LUMINEX HDID BEADS FOR RAPID EVALUATION OF THE QUALITY OF POOLED POSITIVE CONTROL SERUM FOR THE USE IN FLOW CYTOMETRIC CROSSMATCH AND ANTIBODIES SCREENING ASSAYS
Volume: 70 Page(s): S33 - S33
01/01/2009 Authors: Waslaske SH; Marchman CG; McPherson EM; Francia JL; Bray RA; Gebel HM; Moussa O -
IN SILICO vXM COMPARED TO FCXM IN DECEASED DONOR KIDNEY TRANSPLANTS
Volume: 70 Page(s): S29 - S29
01/01/2009 Authors: Lai J; Eckels DD; Gebel HM; Bray RA; Patel P; Katznelson S; Peddi VR; Osorio R; Bry W; Levin BS -
Monitoring after renal transplantation: recommendations and caveats.
Nat Clin Pract Nephrol Volume: 4 Page(s): 658 - 659
12/01/2008 Authors: Bray RA; Gebel HM -
Vitamin K Epoxide Reductase (VKORC1) Genotype Discrepancy Between Donor and Recipient in a Liver Transplant Patient: A Case Report
Volume: 10 Page(s): 569 - 569
11/01/2008 Authors: Melton SD; Foulks C; Hill CE; Gebel H -
HLA alloinimmunization in pediatric sickle cell disease patients: Potential impact for transfusion management
Volume: 48 Page(s): 54A - 54A
09/01/2008 Authors: McPherson M; Anderson A; Jessup P; Castillejo M-I; Bray R; Gebel H; Hillyer C; Josephson C -
Cytotoxicity and antibody binding by flow cytometry: a single assay to simultaneously assess two parameters.
Cytometry B Clin Cytom Volume: 74 Page(s): 287 - 294
09/01/2008 Authors: Saw CL; Bray RA; Gebel HM -
Approaches for transplanting the sensitized patient: biology versus pharmacology.
Nephrol Dial Transplant Volume: 23 Page(s): 2454 - 2457
08/01/2008 Authors: Gebel HM; Bray RA -
Relevance of donor specific antibodies in simultaneous liver kidney transplantation
Volume: 8 Page(s): 378 - 378
05/01/2008 Authors: Agarwal A; Shen LY; Kokko KE; Bray RA; Gebel HM; Pearson TC; Larsen CP; Kirk AD -
Combined liver-kidney transplantation across a positive flow crossmatch: A cause for concern?
Volume: 8 Page(s): 337 - 337
05/01/2008 Authors: Shen LY; Agarwal A; Turgeon NA; Larsen CP; Pearson TC; Bray RA; Gebel HM; Kirk AD; Kokko KE -
Ernst J. Eichwald, MD (1913-2007) - Obituary
AMERICAN JOURNAL OF TRANSPLANTATION Volume: 8 Page(s): 1071 - 1072
05/01/2008 Authors: Cecka JM; Gebel HM -
STANDARDIZATION OF ANTIBODY IDENTIFICATION IN CANADA
Volume: 69 Page(s): S129 - S129
01/01/2008 Authors: Campbell P; Tinckam K; Gebel H; Bray R; Eckels D; Nickerson P -
HLA ALLOIMMUNIZATION IN PEDIATRIC SICKLE CELL DISEASE.
Volume: 69 Page(s): S62 - S62
01/01/2008 Authors: McPherson ME; Anderson AR; Bray RA; Gebel HM; Josephson CD -
Evolution of molecular HLA typing and HLA antibody detection.
Volume: 72B Page(s): 115 - 116
03/01/2007 Authors: Bray RA; Gebel HM -
Standardization of HLA antibody identification across multiple laboratories. Is it feasible?
Volume: 68 Page(s): S117 - S117
01/01/2007 Authors: Campbell P; Bray R; Eckels D; Gebel H -
Influence of HLA-C locus antigens in BK viremia
Volume: 68 Page(s): S15 - S15
01/01/2007 Authors: Mendel B; Newell K; Kokko K; Bray R; Gebel H -
Improved detection of HLA antibodies by labscreen (R) single antigen using a Biotin-Streptavidin complex
Volume: 68 Page(s): S21 - S21
01/01/2007 Authors: Brannon P; Heaney DL; Marchman C; Waslaske S; Saw CL; Gebel HM; Bray RA -
Cytotoxicity and antibody binding by flow cytometry: One assay to assess two parameters
Volume: 68 Page(s): S117 - S117
01/01/2007 Authors: Saw C; Bray RA; Heaney DL; Gebel HM -
LABScreen (R) Mixed vs. Flowpra (R) screen: Which is better for routine monitoring of HLA antibodies?
Volume: 67 Page(s): S76 - S76
10/01/2006 Authors: Heaney DL; Marchman CG; Waslaske SH; Eckels DD; Gebel HM; Bray RA -
Differential expression of HLA class I on B cell subsets
Volume: 67 Page(s): S10 - S10
10/01/2006 Authors: Saw C; Bray RA; Gebel HM -
Cytotoxicity screening in the era of solid phase HLA antibody detection assays: Is it necessary?
Volume: 67 Page(s): S68 - S68
10/01/2006 Authors: Holcomb JE; Gebel HM; Bray RA -
Transplanting the highly sensitized patient: The emory algorithm.
Am J Transplant Volume: 6 Page(s): 2307 - 2315
10/01/2006 Authors: Bray RA; Nolen JDL; Larsen C; Pearson T; Newell KA; Kokko K; Guasch A; Tso P; Mendel JB; Gebel HM -
Repeat/confirmatory HLA typing for stem cell patients; Recommendation or requirement?
Volume: 67 Page(s): S55 - S55
10/01/2006 Authors: Heaney DL; Waslaske SH; Eckels DD; Bray RA; Gebel HM -
Testing a new technology platform for typing HLA alleles (4-MAT (TM))
Volume: 67 Page(s): 557 - 557
06/01/2006 Authors: De Canck I; Mersch G; Dossche I; Adams P; Bray R; Gebel H; Parish G -
A fully-automated screening method for qnti-HLA antibodies: Implications for screening plasma donations to prevent transfusion-related acute lung injury (TRALI)
Volume: 106 Page(s): 282A - 282A
11/16/2005 Authors: Culler E; Barclay SB; Bray RA; Gebel HM; Hillyer CD; Roback JD -
Pra (predictive reactivity of alloantibody); A new approach for crossmatch prediction.
Volume: 5 Page(s): 489 - 489
05/01/2005 Authors: Bray RA; Gebel HM -
Allele-specific HLA alloantibodies: Implicaitons for organ allocation.
Volume: 5 Page(s): 488 - 489
05/01/2005 Authors: Bray RA; Gebel HM -
Comparable graft survival in sensitized and unsensitized renal transplant recipients: A 5 year single center review.
Volume: 5 Page(s): 456 - 456
05/01/2005 Authors: Nolen JDL; Gebel HM; Larsen C; Pearson T; Newell K; Kokko K; Guasch A; Tso P; Bray RA -
Identification of HLA class II antibody specificities in high PRA patients
Volume: 6 Page(s): S69 - S69
04/01/2005 Authors: Pei R; Shih R; Chen M; Bray R; Gebel H; Lee JH -
Masking of HLA antibodies by Thymoglobulin (R)
Volume: 66 Page(s): S12 - S12
01/01/2005 Authors: Gebel HM; Bunce M; Crosby I; Nolen JDL; Bray RA -
Allele-specific HLA alloantibodies and implications for organ allocation
Volume: 66 Page(s): S10 - S10
01/01/2005 Authors: Bray RA; Gebel HM -
A 5 year single center review of graft survival in sensitized renal transplant recipients
Volume: 66 Page(s): S56 - S56
01/01/2005 Authors: Nolen JDL; Bray RA; Pearson T; Larsen C; Newell K; Kokko K; Guasch A; Tso P; Gebel HM -
Pronase treatment facilitates alloantibody flow cytometric and cytotoxic crossmatching in the presence of rituximab.
Hum Immunol Volume: 65 Page(s): 803 - 809
08/01/2004 Authors: Bearden CM; Agarwal A; Book BK; Sidner RA; Gebel HM; Bray RA; Pescovitz MD -
Persistence of low levels of alloantibody after desensitization in crossmatch-positive living-donor kidney transplantation.
Transplantation Volume: 78 Page(s): 221 - 227
07/27/2004 Authors: Gloor JM; DeGoey S; Ploeger N; Gebel H; Bray R; Moore SB; Dean PG; Stegall MD -
Unappreciated risk factors for transplant patients: HLA antibodies in blood components.
Hum Immunol Volume: 65 Page(s): 240 - 244
03/01/2004 Authors: Bray RA; Harris SB; Josephson CD; Hillyer CD; Gebel HM -
Rituximab for reduction of anti-HLA antibodies in patients awaiting renal transplantation: 1. Safety, pharmacodynamics, and pharmacokinetics.
Transplantation Volume: 77 Page(s): 542 - 548
02/27/2004 Authors: Vieira CA; Agarwal A; Book BK; Sidner RA; Bearden CM; Gebel HM; Roggero AL; Fineberg NS; Taber T; Kraus MA -
Flow cytometric assessment of HLA alloantibodies.
Curr Protoc Cytom Volume: Chapter 6 Page(s): Unit - 6.16
02/01/2004 Authors: Bray RA; Gebel HM; Ellis TM -
Evolution of HLA antibody detection: technology emulating biology.
Immunol Res Volume: 29 Page(s): 41 - 54
01/01/2004 Authors: Bray RA; Nickerson PW; Kerman RH; Gebel HM -
Class II donor specific antibodies are pathogenic in primary renal allografts.
Volume: 4 Page(s): 257 - 257
01/01/2004 Authors: Nickerson P; Pochinco D; Karpinski M; Gebel H; Bray R; Gibson I; Rush D; Jeffery J -
Identification of allele-specific HLA class II alloantibodies: Paradigm or paradox
Volume: 65 Page(s): S39 - S39
01/01/2004 Authors: Bray RA; Wilmoth-Hosey L; Chapman P; Holcomb JE; Gebel HM -
Kidney transplantation following administration of high dose intravenous immunoglobulin in patients with positive flow cytometric/negative enhanced cytotoxicity crossmatch.
Volume: 4 Page(s): 256 - 256
01/01/2004 Authors: Gloor JM; Mai ML; DeGoey SR; Larson TS; Gonwa TA; Gebel HM; Bray RA; Moore SB; Genco PV; Stegall MD -
Molecular HLA testing for routine typing of deceased donors
Volume: 65 Page(s): S90 - S90
01/01/2004 Authors: Gebel HM; Wilmoth-Hosey L; Holcomb JE; Chapman P; Bray RA -
Pre-transplant assessment of donor-reactive, HLA-specific antibodies in renal transplantation: contraindication vs. risk.
Am J Transplant Volume: 3 Page(s): 1488 - 1500
12/01/2003 Authors: Gebel HM; Bray RA; Nickerson P -
Prevalence of HLA alloantibodies in blood components using a flow cytometry-based screening assay: Potential clinical implications.
Volume: 100 Page(s): 285A - 285A
11/16/2002 Authors: Harris SB; Gebel HM; Josephson CD; Hillyer CD; Bray RA -
Soluble HLA in saliva of patients with autoimmune rheumatic diseases.
Rheumatol Int Volume: 22 Page(s): 71 - 76
06/01/2002 Authors: Adamashvili I; Pressly T; Gebel H; Milford E; Wolf R; Mancini M; Sittg K; Ghali GE; Hall V; McDonald JC -
Soluble HLA-II expression in African-Americans.
Inflamm Res Volume: 51 Page(s): 290 - 294
06/01/2002 Authors: Adamashvili I; Fraser PA; Milford EL; Sittig K; Gebel H; Zibari G; Pressly T; McDonald JC -
Conundrums with FlowPRA beads.
Clin Transplant Volume: 16 Suppl 7 Page(s): 24 - 29
01/01/2002 Authors: Gebel HM; Harris SB; Zibari G; Bray RA -
HLA antibody and donor reactivity define patients at risk for rejection or graft loss
TISSUE ANTIGENS Volume: 59 Page(s): 60 - 60
01/01/2002 Authors: Kerman RH; Gebel H; Bray R; Garcia C; Sahai R; Gibson H; Radovancevic B; Knight R; Katz S; Van Buren C -
Pancreatic transplantation and subsequent graft surveillance by pancreatic portal-enteric anastomosis and temporary venting jejunostomy.
Ann Surg Volume: 233 Page(s): 639 - 644
05/01/2001 Authors: Zibari GB; Boykin KN; Sawaya DE; Abreo KD; Gonzalez E; Gebel HM; McDonald JC -
Human antibodies to major histocompatibility complex alloantigens mediate lysis and neutralization of HIV-1 primary isolate virions in the presence of complement.
J Acquir Immune Defic Syndr Volume: 26 Page(s): 103 - 110
02/01/2001 Authors: Spear GT; Olinger GG; Saifuddin M; Gebel HM -
Solid-phase HLA antibody detection methods and risk of renal allograft rejection in children.
Transplant Proc Volume: 33 Page(s): 403 - 404
01/01/2001 Authors: Book BK; Agrawal P; Dalla Vecchia LK; Gebel HM; Pescovitz MD; Tambur AR -
Flow PRA to detect clinically relevant HLA antibodies.
Transplant Proc Volume: 33 Page(s): 477
01/01/2001 Authors: Gebel HM; Bray RA; Ruth JA; Zibari GB; McDonald JC; Kahan BD; Kerman RH -
Low-resolution HLA class II typing for solid organ transplantation is inadequate.
Transplant Proc Volume: 33 Page(s): 500
01/01/2001 Authors: Bray RA; Gebel HM -
Pretransplant HLA antibodies detected by FlowPRA (TM) in RAPA-CsA-Pred renal allograft recipients are a risk factor for rejection
Page(s): 17 - 18
01/01/2001 Authors: Kerman R; Gebel H; Przybylowski P; Kahan BD; Bray B -
FlowPRA (TM) detected HLA antibodies can identify clinically relevant FCXM positive crossmatches among heart recipients
Page(s): 35 - 35
01/01/2001 Authors: Przybylowski P; Gebel H; Bray R; Radovancevic B; Frazier OH; Kahan BD; Kerman RH -
Flow cytometric detection of HLA-specific antibodies as a predictor of heart allograft rejection.
Transplantation Volume: 70 Page(s): 1055 - 1059
10/15/2000 Authors: Tambur AR; Bray RA; Takemoto SK; Mancini M; Costanzo MR; Kobashigawa JA; D'Amico CL; Kanter KR; Berg A; Vega JD -
Extracorporeal photopheresis induces lymphocyte but not monocyte apoptosis.
Transplant Proc Volume: 32 Page(s): 747 - 748
06/01/2000 Authors: Tambur AR; Ortegel JW; Morales A; Klingemann H; Gebel HM; Tharp MD -
Moleuclar typing for solid organ transplantation: Is low resolution analysis enough?
TRANSPLANTATION Volume: 69 Page(s): S183 - S183
04/27/2000 Authors: Bray RA; Jones H; Bolin V; Thomas M; Gebel HM -
Sensitization and sensitivity: defining the unsensitized patient.
Transplantation Volume: 69 Page(s): 1370 - 1374
04/15/2000 Authors: Gebel HM; Bray RA -
Detection of HLA antibody is correlated with cardiac allograft rejection
TRANSPLANTATION Volume: 67 Page(s): S101 - S101
04/15/1999 Authors: Takemoto SK; Gebel H; Chuang J; Kobashigawa JA; Cecka JM -
IL-4 inhibits P-glycoprotein in normal and malignant NK cells.
Hum Immunol Volume: 59 Page(s): 483 - 487
08/01/1998 Authors: Tambur AR; Markham PN; Gebel HM -
Cytolysis of eutopic and ectopic endometrial cells by peripheral blood monocytes and peritoneal macrophages in women with endometriosis.
Volume: 69 Page(s): 1103 - 1108
06/01/1998 Authors: Braun DP; Gebel H; Rana N; Dmowski WP -
Spontaneous apoptosis of endometrial tissue is impaired in women with endometriosis.
Fertil Steril Volume: 69 Page(s): 1042 - 1047
06/01/1998 Authors: Gebel HM; Braun DP; Tambur A; Frame D; Rana N; Dmowski WP -
Decreased apoptosis and sensitivity to macrophage mediated cytolysis of endometrial cells in endometriosis.
Hum Reprod Update Volume: 4 Page(s): 696 - 701
01/01/1998 Authors: Dmowski WP; Gebel H; Braun DP -
Screening of the TAP1 gene by denaturing gradient gel electrophoresis in insulin-dependent diabetes mellitus: detection and comparison of new polymorphisms between patients and controls.
Tissue Antigens Volume: 50 Page(s): 576 - 585
12/01/1997 Authors: Yan G; Shi L; Fu Y; Wang X; Schoenfeld D; Ma L; Penfornis A; Gebel H; Faustman DL -
Ultraviolet B irradiation reduces the surface expression of conformationally correct class I and II histocompatibility antigens.
Transplant Proc Volume: 29 Page(s): 2689 - 2691
09/01/1997 Authors: Tambur AR; Foster P; Mellins E; Cresswell P; Faustman D; Gebel HM -
In vivo effects of leflunomide on normal pancreatic islet and syngeneic islet graft function.
Transplantation Volume: 63 Page(s): 716 - 721
03/15/1997 Authors: Guo Z; Chong AS; Shen J; Foster P; Sankary HN; McChesney L; Mital D; Jensik SC; Gebel H; Williams JW -
Flow cytometric detection of HLA alloantibodies using class I coated microparticles.
HUMAN IMMUNOLOGY Volume: 55 Page(s): 36 - 36
01/01/1997 Authors: Bray RA; Cook DJ; Gebel HM -
Leflunomide, a potential immunosuppressant for pancreatic islet transplantation.
Transplant Proc Volume: 29 Page(s): 1296 - 1297
01/01/1997 Authors: Guo Z; Chong AS; Shen J; Foster P; Sankary HN; McChesney L; Mital D; Jensik SC; Gebel H; Williams JW -
Spontaneous apoptosis in the endometrium is impaired in women with endometriosis.
FERTILITY AND STERILITY Page(s): O036 - O036
01/01/1997 Authors: Gebel HM; Frame D; Braun DP; Tambur AR; Rana N; Dmowski WP -
Stimulation of peritoneal macrophage (PM) mediated cytolysis of ectopic endometrial cells (EC) from women with endometriosis (endo pts).
FERTILITY AND STERILITY Page(s): O038 - O038
01/01/1997 Authors: Braun DP; Gebel H; Rana N; Dmowski WP -
Differential sensitivity of resting and IL-2 activated NK cells to R-verapamil.
Transplantation Volume: 62 Page(s): 1883 - 1888
12/27/1996 Authors: Markham PN; Ellis TM; Tambur AR; Gebel HM -
Spontaneous and induced synthesis of cytokines by peripheral blood monocytes in patients with endometriosis.
Fertil Steril Volume: 65 Page(s): 1125 - 1129
06/01/1996 Authors: Braun DP; Gebel H; House R; Rana N; Dmowski NP -
Basal and stimulated secretion of cytokines by peritoneal macrophages in women with endometriosis.
Fertil Steril Volume: 65 Page(s): 925 - 930
05/01/1996 Authors: Rana N; Braun DP; House R; Gebel H; Rotman C; Dmowski WP -
An algorithm for quality control testing of PCR-SSP.
HUMAN IMMUNOLOGY Volume: 47 Page(s): P753 - P753
04/15/1996 Authors: Tambur AR; Braun C; Traczek S; Gebel HM -
Modulation of clip expression by ultraviolet B irradiation.
HUMAN IMMUNOLOGY Volume: 47 Page(s): P513 - P513
04/15/1996 Authors: Gebel HM; Mellins E; Cresswell P; Foster P; Tambur AR -
Effects of leflunomide and other immunosuppressive agents on T cell proliferation in vitro.
Transplantation Volume: 61 Page(s): 140 - 145
01/15/1996 Authors: Chong AS; Rezai K; Gebel HM; Finnegan A; Foster P; Xu X; Williams JW -
Ultraviolet-B irradiation of leukapheresis. Products: dose-response relationship with the mixed lymphocyte reaction.
J Clin Apher Volume: 11 Page(s): 55 - 60
01/01/1996 Authors: Foster PF; Gebel H; McLeod BC; Ebert N; Jensik S; Sankary HN; Tambur A; Williams JW -
Differential expression of VLA beta 1 (CD29) on monocytes from patients with endometriosis.
Am J Reprod Immunol Volume: 34 Page(s): 317 - 322
11/01/1995 Authors: Gebel HM; Rana N; Braun DP; Dmowski WP -
Alloantigen processing and presentation
JOURNAL OF HEART AND LUNG TRANSPLANTATION Volume: 14 Page(s): 1031 - 1037
11/01/1995 Authors: Tambur AR; Gebel HM -
Alloantigen processing and presentation.
J Heart Lung Transplant Volume: 14 Page(s): 1031 - 1037
01/01/1995 Authors: Tambur AR; Gebel HM -
Effect of danazol in vitro and in vivo on monocyte-mediated enhancement of endometrial cell proliferation in women with endometriosis.
Fertil Steril Volume: 62 Page(s): 89 - 95
07/01/1994 Authors: Braun DP; Gebel H; Dmowski WP -
Human leukemia K562 cell mutant (K562/OA200) selected for resistance to okadaic acid (protein phosphatase inhibitor) lacks protein kinase C-epsilon, exhibits multidrug resistance phenotype, and expresses drug pump P-glycoprotein.
J Biol Chem Volume: 269 Page(s): 12332 - 12338
04/22/1994 Authors: Zheng B; Chambers TC; Raynor RL; Markham PN; Gebel HM; Vogler WR; Kuo JF -
Monocyte-mediated enhancement of endometrial cell proliferation in women with endometriosis.
Fertil Steril Volume: 61 Page(s): 78 - 84
01/01/1994 Authors: Braun DP; Muriana A; Gebel H; Rotman C; Rana N; Dmowski WP -
The role of cell-mediated immunity in pathogenesis of endometriosis.
Acta Obstet Gynecol Scand Suppl Volume: 159 Page(s): 7 - 14
01/01/1994 Authors: Dmowski WP; Gebel HM; Braun DP -
Leflunomide, a novel immunosuppressive agent. The mechanism of inhibition of T cell proliferation.
Transplantation Volume: 55 Page(s): 1361 - 1366
06/01/1993 Authors: Chong AS; Finnegan A; Jiang X; Gebel H; Sankary HN; Foster P; Williams JW -
Mitogen induced production of polyclonal IgG is decreased in women with severe endometriosis.
Am J Reprod Immunol Volume: 29 Page(s): 124 - 130
03/01/1993 Authors: Gebel HM; Braun DP; Rotman C; Rana N; Dmowski WP -
Leflunomide, a novel immunomodulatory agent: in vitro analyses of the mechanism of immunosuppression.
Volume: 25 Page(s): 747 - 749
02/01/1993 Authors: Chong AS; Gebel H; Finnegan A; Petraitis EE; Jiang XL; Sankary HN; Foster P; Williams JW -
Natural killer cell cytotoxicity and the multidrug resistance gene.
Transplant Proc Volume: 25 Page(s): 96 - 97
02/01/1993 Authors: Markham PN; Coon JS; Chong AS; Gebel HM -
Diverse multidrug-resistance-modification agents inhibit cytolytic activity of natural killer cells.
Cancer Immunol Immunother Volume: 36 Page(s): 133 - 139
01/01/1993 Authors: Chong AS; Markham PN; Gebel HM; Bines SD; Coon JS -
OKT3 INDUCTION OF CLASS-II ANTIGENS
HUMAN IMMUNOLOGY Volume: 37 Page(s): 100 - 100
01/01/1993 Authors: PROD MH; JENSIK S; PHELAN DL; GEBEL HM -
The development of cytotoxicity in peritoneal macrophages from women with endometriosis.
Fertil Steril Volume: 57 Page(s): 1203 - 1210
06/01/1992 Authors: Braun DP; Gebel H; Rotman C; Rana N; Dmowski WP -
Characterization of peripheral blood CD8/11b cells in bone marrow transplant recipients. III. Subsets of CD8/11b cells differentially regulate immunoglobulin production.
Bone Marrow Transplant Volume: 9 Page(s): 35 - 39
01/01/1992 Authors: Lebeck LK; Kaizer H; Gebel HM -
Multidrug resistance activity in human lymphocytes.
Hum Immunol Volume: 32 Page(s): 134 - 140
10/01/1991 Authors: Coon JS; Wang YZ; Bines SD; Markham PN; Chong AS; Gebel HM -
Crossmatch procedures used in organ transplantation.
Clin Lab Med Volume: 11 Page(s): 603 - 620
09/01/1991 Authors: Gebel HM; Lebeck LK -
Detection of cytotoxic T lymphocytes specific for synthetic peptides of gp160 in HIV-seropositive individuals.
J Immunol Volume: 146 Page(s): 2214 - 2219
04/01/1991 Authors: Clerici M; Lucey DR; Zajac RA; Boswell RN; Gebel HM; Takahashi H; Berzofsky JA; Shearer GM -
Two populations of CD56 (Leu-19)+/CD16+ cells in bone marrow transplant recipients.
Bone Marrow Transplant Volume: 5 Page(s): 259 - 264
04/01/1990 Authors: Gottschalk LR; Bray RA; Kaizer H; Gebel HM -
Endometriosis: genetic and immunologic aspects.
Prog Clin Biol Res Volume: 323 Page(s): 99 - 122
01/01/1990 Authors: Dmowski WP; Braun D; Gebel H -
The flow cytometric crossmatch. Dual-color analysis of T cell and B cell reactivities.
Transplantation Volume: 48 Page(s): 834 - 840
11/01/1989 Authors: Bray RA; Lebeck LK; Gebel HM -
T cells from patients successfully treated with OKT3 do not react with the T-cell receptor antibody.
Hum Immunol Volume: 26 Page(s): 123 - 129
10/01/1989 Authors: Gebel HM; Lebeck LK; Jensik SC; Webster K; Bray RA -
Immunologic aspects of endometriosis.
Obstet Gynecol Clin North Am Volume: 16 Page(s): 93 - 103
03/01/1989 Authors: Dmowski WP; Gebel HM; Rawlins RG -
Discordant expression of CD3 and T-cell receptor antigens on lymphocytes from patients treated with OKT3.
Transplant Proc Volume: 21 Page(s): 1745 - 1746
02/01/1989 Authors: Gebel HM; Lebeck LL; Jensik SC; Landay AL; Bray RA -
DISCORDANT EXPRESSION OF CD3 AND T-CELL RECEPTOR ANTIGENS ON LYMPHOCYTES FROM PATIENTS TREATED WITH OKT3
TRANSPLANTATION PROCEEDINGS Volume: 21 Page(s): 1745 - 1746
02/01/1989 Authors: GEBEL HM; LEBECK LL; JENSIK SC; LANDAY AL; BRAY RA -
Rejection of renal allografts: prediction with a new peripheral blood assay.
Curr Surg Volume: 46 Page(s): 13 - 15
01/01/1989 Authors: Kelly M; Gebel H; Jensik S; Williams J; Anderson J -
Lymphocyte responsiveness after irradiation in canine and human intestinal allografts.
Curr Surg Volume: 46 Page(s): 16 - 19
01/01/1989 Authors: Tattersall C; Gebel H; Haklin M; Hartsell W; Williams J -
LACK OF T-CELL RECEPTOR MOLECULES ON LYMPHOCYTES-CD3 FROM PATIENTS TREATED WITH OKT3
HUMAN IMMUNOLOGY Volume: 23 Page(s): 99 - 100
10/01/1988 Authors: GEBEL HM; LEBECK LL; JENSIK SC; BRAY RA -
DISCRIMINATION OF CLASS-I ANTIBODIES IN THE FLOW CYTOMETRIC CROSSMATCH (FCXM)
HUMAN IMMUNOLOGY Volume: 23 Page(s): 83 - 83
10/01/1988 Authors: BRAY RA; GEBEL HM -
Characterization of peripheral blood CD8/11 cells in bone marrow transplant recipients. II. Two distinct populations of CD8/11 cells.
Transplantation Volume: 45 Page(s): 890 - 894
05/01/1988 Authors: Gottschalk LR; Kaizer H; Gebel HM -
NATURAL-KILLER CELL SUBPOPULATIONS IN BONE-MARROW TRANSPLANT RECIPIENTS
FASEB JOURNAL Volume: 2 Page(s): A1851 - A1851
03/25/1988 Authors: LANDAY AL; GOTTSCHALK LR; BRAY RA; GEBEL HM -
EXTENDED CARDIAC ALLOGRAFT SURVIVAL IN RECIPIENTS TREATED ONLY WITH PRETRANSPLANT CYCLOSPORINE
TRANSPLANTATION PROCEEDINGS Volume: 20 Page(s): 157 - 157
02/01/1988 Authors: GEBEL HM; UMEKI Y; MACLEOD C; ECONOMOU SG -
ELIMINATION OF IA+ PASSENGER CELLS IN RAT HEARTS
TRANSPLANTATION PROCEEDINGS Volume: 20 Page(s): 78 - 80
02/01/1988 Authors: GEBEL HM; UMEKI Y; ECONOMOU SG -
The characterization of Ia+ cells in human parathyroid and islets.
J Surg Res Volume: 44 Page(s): 117 - 120
02/01/1988 Authors: Bloom AD; Kiggens-Leifheit A; Johnson BL; Economou SG; Jensik SC; Gebel HM -
T-cell receptor gene rearrangement and expression in human natural killer cells: natural killer activity is not dependent on the rearrangement and expression of T-cell receptor alpha, beta, or gamma genes.
Immunogenetics Volume: 27 Page(s): 231 - 238
01/01/1988 Authors: Leiden JM; Gottesdiener KM; Quertermous T; Coury L; Bray RA; Gottschalk L; Gebel H; Seidman JG; Strominger JL; Landay AL -
2 POPULATIONS OF LARGE ANTIGRANULOCYTES LYMPHOCYTES IN BONE-MARROW RECIPIENTS
JOURNAL OF LEUKOCYTE BIOLOGY Volume: 42 Page(s): 381 - 381
10/01/1987 Authors: GEBEL H; KAIZER H; GOTTSCHALK L -
DUAL ROLE FOR IL-2 IN ACTIVATION AND MATURATION OF HUMAN NK CELLS
JOURNAL OF LEUKOCYTE BIOLOGY Volume: 42 Page(s): 380 - 380
10/01/1987 Authors: GEBEL H; LANDAY A; BRAY R -
Extension of survival of rat parathyroid allografts by depletion of Ia donor cells plus preoperative cyclosporine.
Transplantation Volume: 44 Page(s): 171 - 174
08/01/1987 Authors: Bloom AD; Economou SG; Gebel HM -
Multiple sclerosis and systemic lupus erythematosus. Occurrence in two generations of the same family.
Arch Intern Med Volume: 147 Page(s): 1317 - 1320
07/01/1987 Authors: Sloan JB; Berk MA; Gebel HM; Fretzin DF -
Differential surface marker expression in patients with CD-16+ lymphoproliferative disorders: in vivo model for NK differentiation.
Hum Immunol Volume: 19 Page(s): 105 - 115
06/01/1987 Authors: Bray RA; Gottschalk LR; Landay AL; Gebel HM -
IMMUNOLOGICAL REJECTION OF A RENAL-ALLOGRAFT - PREDICTION WITH A NEW PERIPHERAL-BLOOD ASSAY
FEDERATION PROCEEDINGS Volume: 46 Page(s): 1356 - 1356
03/05/1987 Authors: KELLY M; GEBEL H; WILLIAMS J; JENSIK S; ECONOMOU S; ANDERSON J -
AN IMPROVED TECHNIQUE FOR CARDIAC ALLOTRANSPLANTATION
FEDERATION PROCEEDINGS Volume: 46 Page(s): 1356 - 1356
03/05/1987 Authors: UMEKI Y; WEINRIB H; ECONOMOU SG; GEBEL HM -
REJECTION OF TRANSPLANTED ORGANS - A NEW METHOD OF DETECTION
FEDERATION PROCEEDINGS Volume: 46 Page(s): 1357 - 1357
03/05/1987 Authors: ANDERSON J; KELLY M; ECONOMOU S; JENSIK S; WILLIAMS J; GEBEL H -
FUNCTIONAL-CHARACTERIZATION OF CD8/11 CELLS IN BONE-MARROW RECIPIENTS
FEDERATION PROCEEDINGS Volume: 46 Page(s): 1360 - 1360
03/05/1987 Authors: GOTTSCHALK L; KAIZER H; GEBEL HM -
AN INVIVO MODEL TO STUDY NK-CELL DIFFERENTIATION
FEDERATION PROCEEDINGS Volume: 46 Page(s): 608 - 608
03/01/1987 Authors: BRAY RA; GOTTSCHALK LR; LANDAY AL; GEBEL HM -
Prolonged survival of endocrine allografts with preoperative cyclosporine A.
Transplant Proc Volume: 19 Page(s): 946 - 949
02/01/1987 Authors: Gebel HM; Bloom A; McErlean J; Leifheit AK; Economou S -
Characterization of circulating suppressor T lymphocytes in bone marrow transplant recipients.
Transplantation Volume: 43 Page(s): 258 - 263
02/01/1987 Authors: Gebel HM; Kaizer H; Landay AL -
PROLONGED SURVIVAL OF ENDOCRINE ALLOGRAFTS WITH PREOPERATIVE CYCLOSPORINE-A
TRANSPLANTATION PROCEEDINGS Volume: 19 Page(s): 946 - 949
02/01/1987 Authors: GEBEL HM; BLOOM A; MCERLEAN J; LEIFHEIT AK; ECONOMOU S -
Determination of helper:suppressor T-cell ratios.
N Engl J Med Volume: 316 Page(s): 113
01/08/1987 Authors: Gebel HM; Anderson JE; Gottschalk LR; Bray RA -
Prolonged survival of rat parathyroid allografts after preoperative treatment with cyclosporine A.
Curr Surg Volume: 44 Page(s): 205 - 207
01/01/1987 Authors: Bloom AD; Economou SG; Baker JW; Gebel HM -
New method for cardiac transplantation.
Microsurgery Volume: 8 Page(s): 122 - 124
01/01/1987 Authors: Umeki Y; Weinrib HP; MacLeod CA; Economou SG; Gebel HM -
CD16+ NK lymphoproliferative disorders: cellular and molecular characterization.
Nat Immun Cell Growth Regul Volume: 6 Page(s): 141 - 149
01/01/1987 Authors: Landay A; Gebel H; Levin S; Prasthofer E; Pistoia V; Downing J; Grossi C -
Indefinite survival of rat parathyroid allografts without postoperative immunosuppression.
Surgery Volume: 100 Page(s): 1032 - 1038
12/01/1986 Authors: Bloom AD; Economou SG; Gebel HM -
FLOW CYTOMETRIC ANALYSIS OF ACTIVATED LYMPHOCYTES FROM TRANSPLANT RECIPIENTS
HUMAN IMMUNOLOGY Volume: 17 Page(s): 118 - 119
10/01/1986 Authors: ANDERSON J; JOHNSON D; LANDAY A; WILLIAMS J; ECONOMOU S; GEBEL H -
THE CHARACTERIZATION OF PASSENGER CELLS IN HUMAN PARATHYROID TISSUE
HUMAN IMMUNOLOGY Volume: 17 Page(s): 117 - 117
10/01/1986 Authors: BLOOM A; LEIFHEIT AK; JOHNSON B; ECONOMOU S; JENSIK S; GEBEL H -
INDEFINITE SURVIVAL OF ENDOCRINE ALLOGRAFTS WITH NO POSTOPERATIVE IMMUNOSUPPRESSION
HUMAN IMMUNOLOGY Volume: 17 Page(s): 108 - 108
10/01/1986 Authors: GEBEL H; UMEKI Y; ECONOMOU S; BLOOM A -
DIFFERENTIAL EXPRESSION OF HLA-DR AND DQ ON NK-CELLS - POSSIBLE RELATIONSHIP TO NK-ONTOGENY
HUMAN IMMUNOLOGY Volume: 17 Page(s): 208 - 208
10/01/1986 Authors: GOTTSCHALK L; BRAY RA; LANDAY A; KAIZER H; GEBEL H -
ALTERATIONS IN MONOCYTE FUNCTION IN PATIENTS AT RISK FOR AIDS
JOURNAL OF LEUKOCYTE BIOLOGY Volume: 40 Page(s): 265 - 266
09/01/1986 Authors: LANDAY A; GEBEL H; HARRIS JE; PAUL D; DAWSON G; FALK L; BRAUN DP -
ISLETS WITH IA+ PASSENGER CELLS STIMULATE ALLOGENEIC LYMPHOCYTE-PROLIFERATION
HUMAN IMMUNOLOGY Volume: 14 Page(s): 111 - 111
01/01/1985 Authors: GEBEL HM; KIGGENSLIEFHEIT A -
SUPPRESSION OF INTERLEUKIN-2 PRODUCTION - PROBABLE MEDIATION BY LEU 2+, 15+, DR+ T-CELLS OBTAINED FROM BONE-MARROW TRANSPLANT RECIPIENTS
EXPERIMENTAL HEMATOLOGY Volume: 13 Page(s): 434 - 434
01/01/1985 Authors: GEBEL HM; KAIZER H; LANDAY AL -
LONG-TERM SURVIVAL OF PARATHYROID ALLOGRAFTS AFTER PREOPERATIVE TREATMENT OF RECIPIENTS WITH CYCLOSPORINE-A
HUMAN IMMUNOLOGY Volume: 14 Page(s): 175 - 176
01/01/1985 Authors: BLOOM AD; ECONOMOU SG; GEBEL HM -
CLASS-II BEARING CELLS IN/ON HUMAN ISLETS
HUMAN IMMUNOLOGY Volume: 12 Page(s): 109 - 110
01/01/1985 Authors: GEBEL HM; TERESAKA R; HAUPTFELD V; FINKE EH; LACY PE -
PREVENTION OF MOUSE ISLET ALLOGRAFT-REJECTION BY ELIMINATION OF INTRAISLET DENDRITIC CELLS
TRANSPLANTATION PROCEEDINGS Volume: 17 Page(s): 420 - 422
01/01/1985 Authors: FAUSTMAN DL; STEINMAN RM; GEBEL HM; HAUPTFELD V; DAVIE JM; LACY PE -
DISTINCTIVE T-CELLS IN BONE-MARROW TRANSPLANT RECIPIENTS - EXPRESSION OF HLA-DQ MOLECULES ON A SUBPOPULATION OF LYMPHOCYTES-T
HUMAN IMMUNOLOGY Volume: 14 Page(s): 175 - 175
01/01/1985 Authors: GEBEL HM; KAIZER H; LANDAY AL -
Prevention of rejection of murine islet allografts by pretreatment with anti-dendritic cell antibody.
Proc Natl Acad Sci U S A Volume: 81 Page(s): 3864 - 3868
06/01/1984 Authors: Faustman DL; Steinman RM; Gebel HM; Hauptfeld V; Davie JM; Lacy PE -
Antibodies directed against HLA-DR gene products exhibit the CYNAP phenomenon.
Tissue Antigens Volume: 23 Page(s): 135 - 140
03/01/1984 Authors: Gebel HM; Oldfather JW; Karr RW; Fuller TC; Rodey GE -
IMMUNOSTIMULATION WITH BCG VACCINE IN THE MANAGEMENT OF ALZHEIMERS-DISEASE (AD)
GERONTOLOGIST Volume: 24 Page(s): 162 - 163
01/01/1984 Authors: TORACK R; DYE C; GRANT E; GEBEL H -
Thymectomy-induced decrease in T gamma cells and OKT8+ cells in multiple sclerosis.
Ann Neurol Volume: 14 Page(s): 656 - 661
12/01/1983 Authors: Trotter JL; Gebel HM; Ferguson TB; Garvey WF; Rodey GE -
Ia-bearing cells within isolated canine islets.
Transplantation Volume: 36 Page(s): 346 - 348
09/01/1983 Authors: Gebel HM; Yasunami Y; Diekgraefe B; Davie JM; Lacy PE -
Cutaneous anergy and marrow suppression as complications of gastroplasty for morbid obesity.
Surgery Volume: 94 Page(s): 109 - 111
07/01/1983 Authors: Schneider SB; Erikson N; Gebel HM; Wedner HJ; Denes AE; Halverson JD -
Detection of two distinct public specificities on HLA-A28 bearing lymphocytes.
Tissue Antigens Volume: 22 Page(s): 16 - 23
07/01/1983 Authors: Oldfather JW; Gebel HM; Holmes DJ; Rodey GE -
In vitro response of human T cells to Pseudomonas aeruginosa.
Infect Immun Volume: 40 Page(s): 670 - 674
05/01/1983 Authors: Porwoll JM; Gebel HM; Rodey GE; Markham RB -
INVITRO IMMUNIZATION TO KLH .2. LIMITING DILUTION ANALYSIS OF ANTIGEN-REACTIVE CELLS IN PRIMARY AND SECONDARY CULTURE
JOURNAL OF IMMUNOLOGY Volume: 130 Page(s): 29 - 32
01/01/1983 Authors: GEBEL HM; SCOTT JR; PARVIN CA; RODEY GE -
A METHOD FOR THE MASS ISOLATION OF ISLETS FROM THE CANINE PANCREAS
DIABETOLOGIA Volume: 25 Page(s): 174 - 174
01/01/1983 Authors: LACY P; FINKE E; GEBEL H; SCHARP D -
In vitro immunization to KLH. II. Limiting dilution analysis of antigen-reactive cells in primary and secondary culture.
J Immunol Volume: 130 Page(s): 29 - 32
01/01/1983 Authors: Gebel HM; Scott JR; Parvin CA; Rodey GE -
Demonstration of a third structurally distinct human Ia beta chain by two-dimensional gel electrophoresis.
J Exp Med Volume: 156 Page(s): 652 - 657
08/01/1982 Authors: Karr RW; Kannapell CC; Stein JA; Fuller TC; Duquesnoy RJ; Rodey GE; Mann DL; Gebel HM; Schwartz BD -
Antigenic specificity of antibody reactive in the antiglobulin-augmented lymphocytotoxicity test.
Transplantation Volume: 34 Page(s): 24 - 29
07/01/1982 Authors: Fuller TC; Phelan D; Gebel HM; Rodey GE -
Molecular relationships of the human B cell alloantigens, MT2, MB3, MT4, and DR5.
J Immunol Volume: 128 Page(s): 1809 - 1818
04/01/1982 Authors: Karr RW; Kannapell CC; Stein JA; Gebel HM; Mann DL; Duquesnoy RJ; Fuller TC; Rodey GE; Schwartz BD -
Azathioprine decreases suppressor T cells in patients with multiple sclerosis.
N Engl J Med Volume: 306 Page(s): 365 - 366
02/11/1982 Authors: Trotter JL; Rodey GE; Gebel HM -
LIMITING DILUTION ANALYSIS OF ANTIGEN REACTIVE CELLS SENSITIZED INVITRO
HUMAN IMMUNOLOGY Volume: 5 Page(s): 152 - 152
01/01/1982 Authors: GEBEL H; SCOTT J; PARVIN C; RODY G -
Delayed hypersensitivity in Alzheimer's disease following BCG immunostimulation.
Clin Neuropathol Volume: 1 Page(s): 169 - 171
01/01/1982 Authors: Torack RM; Gebel HM -
DEFECTIVE T-CELL ACTIVITY IN PATIENTS WITH MULTIPLE-SCLEROSIS
FEDERATION PROCEEDINGS Volume: 41 Page(s): 954 - 954
01/01/1982 Authors: GEBEL HM; TROTTER JL; RODEY GE -
LIMITING DILUTION ANALYSIS OF INVITRO IMMUNIZED HUMAN-BLOOD LYMPHOCYTES
FEDERATION PROCEEDINGS Volume: 40 Page(s): 1033 - 1033
01/01/1981 Authors: GEBEL HM; SCOTT JR; RADAJ PA; RODEY GE -
LYMPHOCYTE-T DEFECTS IN PATIENTS WITH MULTIPLE-SCLEROSIS
CLINICAL RESEARCH Volume: 29 Page(s): A735 - A735
01/01/1981 Authors: GEBEL HM; RODEY GE -
Occurrence and potential significance of increased numbers of T cells with Fc receptors in myeloma.
Immunol Rev Volume: 56 Page(s): 115 - 139
01/01/1981 Authors: Hoover RG; Gebel HM; Dieckgraefe BK; Hickman S; Rebbe NF; Hirayama N; Ovary Z; Lynch RG -
Expansion of Fc receptor-bearing T lymphocytes in patients with immunoglobulin G and immunoglobulin A myeloma.
J Clin Invest Volume: 67 Page(s): 308 - 311
01/01/1981 Authors: Hoover RG; Hickman S; Gebel HM; Rebbe N; Lynch RG -
Functional characteristics of TG and TnonG cells in a three party MLR.
J Immunol Volume: 126 Page(s): 118 - 121
01/01/1981 Authors: Gebel HM; Radaj PA; Holmes D; Schwartz BD; Rodey GE -
MITOGEN-INDUCED PLASMA-CELL DIFFERENTIATION IN PATIENTS WITH MULTIPLE-SCLEROSIS EVIDENCE SUPPORTING A T-CELL DEFECT
HUMAN IMMUNOLOGY Volume: 3 Page(s): 363 - 363
01/01/1981 Authors: GEBEL HM; ROSS L; TROTTER J; RODEY GE -
INDUCED DECREASE IN PERCENTAGE OF TG-CELLS AND SUPPRESSOR ACTIVITY IN THE PERIPHERAL-BLOOD OF PATIENTS WITH MULTIPLE-SCLEROSIS
ANNALS OF NEUROLOGY Volume: 10 Page(s): 97 - 97
01/01/1981 Authors: TROTTER JL; GEBEL HM; GARVEY WF; FERGUSON TB; RAMMOHAN KW; RODEY GE -
INDUCED DECREASE IN PERIPHERAL-BLOOD PERCENTAGE OF T-ALPHA-CELLS AND SUPPRESSOR (CON-A) ACTIVITY IN MULTIPLE-SCLEROSIS PATIENTS
TRANSACTIONS OF THE AMERICAN NEUROLOGICAL ASSOCIATION Volume: 106 Page(s): 281 - 282
01/01/1981 Authors: TROTTER JL; GEBEL HM; GARVEY WF; FERGUSON TF; MONTGOMERY EB; CLIFFORD DB; RAMMAHAN KW; RODEY GE -
THE DEMONSTRATION OF 2 DISTINCT PUBLIC SPECIFICITIES ON HLA-A28 BEARING CELLS
HUMAN IMMUNOLOGY Volume: 3 Page(s): 378 - 379
01/01/1981 Authors: OLDFATHER JW; GEBEL HM; HOLMES DJ; RODEY GE -
Antigen-binding myeloma cells: monoclonal models of B cell differentiation.
Prog Clin Biol Res Volume: 42 Page(s): 325 - 344
01/01/1980 Authors: Lynch RG; Rohrer JW; Gebel HM; Odermatt BF; Hoover RG; Milburn GL; Mordhorst R -
RELATIONSHIP OF THE CYNAP PHENOMENON AND ANTIGLOBULIN-AUGMENTED LYMPHOCYTOTOXICITY
HUMAN IMMUNOLOGY Volume: 1 Page(s): 275 - 275
01/01/1980 Authors: PHELAN D; GEBEL H; FULLER T; RODEY G -
HLA AND ITS RELATIONSHIP TO DISEASES
AMERICAN JOURNAL OF MEDICAL TECHNOLOGY Volume: 46 Page(s): 331 - 331
01/01/1980 Authors: GEBEL HM -
Lymphocyte surface membrane immunoglobulin in myeloma. I. M315-bearing T lymphocytes in mice with MOPC-315.
J Immunol Volume: 123 Page(s): 1110 - 1116
09/01/1979 Authors: Gebel HM; Hoover RG; Lynch RG -
Inactivation of complement by Loxosceles reclusa spider venom.
Am J Trop Med Hyg Volume: 28 Page(s): 756 - 762
07/01/1979 Authors: Gebel HM; Finke JH; Elgert KD; Cambell BJ; Barrett JT -
Chemotactic activity of venom from the brown recluse spider (Loxoscelles reclusa).
Toxicon Volume: 17 Page(s): 55 - 60
01/01/1979 Authors: Gebel HM; Campbell BJ; Barrett JT -
IMMUNOREGULATION OF ANTIGEN-BINDING MYELOMA CELLS BY T-CELL DERIVED ANTIGEN-SPECIFIC AND IDIOTYPE-SPECIFIC FACTORS - EFFECT OF SIMULTANEOUS PRESENTATION OF HELPER AND SUPPRESSOR SIGNALS
JOURNAL OF SUPRAMOLECULAR STRUCTURE Page(s): 292 - 292
01/01/1979 Authors: GEBEL HM; ROHRER JW; LYNCH RG -
IS THE 315-P TUMOR AN IGA LYMPHOMA - REPLY
JOURNAL OF THE NATIONAL CANCER INSTITUTE Volume: 63 Page(s): 538 - 539
01/01/1979 Authors: GEBEL HM; AUTRY JR; ROHRER JW; LYNCH RG -
M-COMPONENT-BEARING LYMPHOCYTES IN MURINE MYELOMA - CELLULAR ORIGIN, AND RELATIONSHIP TO M-COMPONENT SECRETION AND HUMORAL IMMUNODEFICIENCY
FEDERATION PROCEEDINGS Volume: 38 Page(s): 1426 - 1426
01/01/1979 Authors: GEBEL HM; HOOVER RG; LYNCH RG -
In vitro and in vivo studies of a 2,4,6-trinitrophenyl (TNP)-binding immunoglobulin A (IgA) lymphoma isolated from MOPC-315, a TNP-binding IgA plasmacytoma of BALB/c mice.
J Natl Cancer Inst Volume: 62 Page(s): 201 - 211
01/01/1979 Authors: Gebel HM; Autry JR; Rohrer JW; Lynch RG -
Immunoregulation of murine myeloma cell growth and differentiation: a monoclonal model of B cell differentiation.
Immunol Rev Volume: 48 Page(s): 45 - 80
01/01/1979 Authors: Lynch RG; Rohrer JW; Odermatt B; Gebel HM; Autry JR; Hoover RG -
REGULATION OF HAPTEN-SPECIFIC MYELOMA CELLS BY T-CELL-DERIVED ANTIGEN-SPECIFIC AND IDIOTYPE-SPECIFIC FACTORS - EFFECTS OF SIMULTANEOUS PRESENTATION OF HELPER AND SUPPRESSOR SIGNALS
FEDERATION PROCEEDINGS Volume: 38 Page(s): 1283 - 1283
01/01/1979 Authors: ROHRER JW; GEBEL HM; LYNCH RG -
Idiotype-specific transplantation resistance to MOPC-315: abrogation by post-immunization thymectomy.
J Immunol Volume: 120 Page(s): 1620 - 1624
05/01/1978 Authors: Daley MJ; Gebel HM; Lynch RG -
INVIVO AND INVITRO STUDIES OF A TNP-BINDING IGA LYMPHOMA ISOLATED FROM MOPC-315 A TNP-BINDING IGA PLASMACYTOMA OF BALB-C MICE
FEDERATION PROCEEDINGS Volume: 37 Page(s): 486 - 486
01/01/1978 Authors: AUTRY JR; GEBEL HM; DIBNER J; LYNCH RG -
IDIOTYPE-SPECIFIC SUPPRESSION OF MOPC-315 - ABROGATION BY POST-IMMUNIZATION THYMECTOMY
FEDERATION PROCEEDINGS Volume: 37 Page(s): 1453 - 1453
01/01/1978 Authors: GEBEL HM; DALEY MJ; LYNCH RG -
ISOLATION OF A DNP-BINDING IGA LYMPHOMA LINE FROM MOPC-315 A DNP-BINDING PLASMACYTOMA OF BALB-C MICE
JOURNAL OF SUPRAMOLECULAR STRUCTURE Page(s): 178 - 178
01/01/1978 Authors: GEBEL HM; AUTRY JR; LYNCH RG -
INTERACTIONS OF COMPLEMENT WITH RECLUSE SPIDER VENOM
FEDERATION PROCEEDINGS Volume: 35 Page(s): 358 - 358
01/01/1976 Authors: FINKE JH; ELGERT KD; GEBEL HM; CAMPBELL BJ; BARRETT JT